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Abstract 
Carbapenem-resistant Enterobacteriaceae (CRE) health care acquired infections are a 
serious public health threat due to a high mortality rate, economic burden, and depletion 
of last resort CRE antimicrobials. CRE infections have emerged as community-associated 
type infections in the United States. For CRE to now have that type of potential is cause 
for immediate and extensive action. The prevalence of CRE infection cases that were 
reported as community-associated CRE and health care acquired CRE by examining 
specific clinical characteristics between 4 selected states that were reported to respective 
state health departments and the Centers for Disease Control were explored in this study. 
The theoretical framework most appropriate for this study was the One Health 
foundation. Two research questions were formulated to address the association of the 
CRE clinical characteristics (organism identification, specimen source, medical facility 
type, and laboratory detection method) and the health care acquired Carbapenemase gene 
mechanism between 4 selected states (Colorado, Illinois, West Virginia, and South 
Dakota). For this quantitative retrospective study, secondary data was used with the 
Goodman and Kruskal’s lambda analysis. For the 1st time a significant relationship for 
the clinical characteristics of organism identification and lab gene detection method 
between the 4 selected U.S. states were established in this study. No relationships were 
established for the other 3 characteristics but provided insight for future studies. The 
positive social implication from this study was being able to formulate CRE predictive 
knowledge that could contribute to the reduction of CRE cases and provide vision to 
possible reasons why CRE has emerged as community-associated in the United States. 
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Chapter 1: Introduction to the Study 
A serious public health threat has been steadily on the rise worldwide since 2000, 
which is bacterial infections caused by resistance gram-negative bacteria (Kaye & Pogue, 
2015). These types of infections are difficult to treat and are categorized as having high 
morbidity and mortality rates, which are commonly referred to as antimicrobial resistance 
(AMR) (Chandler et al., 2016; Kaye & Pogue, 2015). As of 2015, AMR cases have been 
estimated to affect approximately 2 million patients in the United States resulting in 
approximately 23,000 deaths per year, which is a substantial clinical burden (Kaye & 
Pogue, 2015). As of 2017, the Centers for Disease Control and Prevention (CDC) 
estimated that AMR has a substantial economic burden resulting in more than $20 billion 
per year for health care costs and approximately an additional $35 billion per year to 
society in lost productivity (van Duin & Doi, 2017).  
AMR is a problem domestically and globally, and it has a complex epidemiology 
that includes multiple levels (Queenan et al., 2016). The U.S. government has issued an 
official National Action Plan for combating antibiotic resistant bacteria, which means that 
the United States has enlisted help to provide further guidance to work domestically and 
globally to prevent, detect, and control antibiotic-resistant bacteria infections that lead to 
severe illnesses and deaths (The White House, 2015). In this study, I focused on a 
specific AMR issue, which is Carbapenem-resistant Enterobacteriaceae (CRE) and the 
community-associated threats in the United States. (Lee et al., 2016). Due to the 
seriousness of carbapenem antibiotics being considered the last resort treatment for 
patients with highly resistant gram-negative bacterial infections, community-associated 
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implications are also a serious threat (Guh et al., 2015). Little research has been done to 
explore how CRE infections have emerged into being acquired through community-
associated transmissions in the United States in addition to the already-established health 
care acquired transmissions. 
Chapter 1 is a summarized overview that includes a brief introduction of AMR, 
which is followed by background information on CRE about how in the past it has been 
associated with only health care acquired infections. The problem statement includes 
evidence with regard to the significance and relevance of how CRE is a threat to the well-
being of the public health population in the United States. The overview continues with 
my purpose in the study, which includes details on the dependent and independent 
variables for this study. The research questions, hypotheses, and theoretical framework 
are the main conductors for this research. Chapter 1 also includes information about the 
nature of this study, conceptual definitions, assumptions, scope and delimitations, and 
limitations. Chapter 1 concludes information about the significance of the study and a 
summary, which transitions into the literature review that I present in Chapter 2.  
Background 
CRE infections have become a serious emerging public health threat (Bartsch et 
al., 2017; CDC, 2013a; Lee et al., 2016; Tängdén & Giske, 2015). Carbapenems are a 
class of antibiotics considered to be the last resort antimicrobial agents and are used to 
treat bacterial infections caused by highly resistant organisms (Lee & Doi, 2014). CRE 
are considered nonsusceptible to the carbapenem class of antibiotics, which creates 
limited treatment options for infected patients (CDC, 2015a). CRE infections have one of 
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the highest mortality/morbidity rates of which some studies have reported a mortality rate 
to be as high as 40% to 50% for invasive type infections such as bloodstream infections 
acquired in acute care hospitals and/or long-term care facilities (LTCFs) (CDC, 2015a).  
As of 2013, the CDC has documented at least 1 type of infection that has been 
confirmed as CRE from 42 states within the past 10 years, but from only health care type 
facilities with other specific characteristic details being sparse (CDC, 2013b). In 2014, 
the Association for Professional in Infection Control and Epidemiology (APIC) compiled 
a summary of states that report CRE and have reporting requirements on approximately 
19 individual states that voluntarily and routinely define, track, and report CRE cases 
along with specific collected characteristics to their respective state public health 
departments (APIC, 2017). It is important to carefully monitor and track the emergence 
of highly infectious bacterial infections, especially once that infectious state starts to 
migrate from familiar environments to unfamiliar circumstances. Health organizations 
that have the abilities to have some type of AMR tracking programs have not always 
obtained data comprehensively due to practices such as incomplete reporting, practice 
variance in diagnostics, and undefined or changing definitions for gene resistant 
phenotype (van Duin & Doi, 2017).   
Historically, CRE infections have always been associated with being acquired 
only within health care facilities in the United States, so with some CRE infection cases 
now classified as community-associated instead of only health care acquired, this has 
necessitated a need for an extensive literature review on what could be the causes behind 
cases of CRE infections acquired through community type exposures (CDC, 2015b; 
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Saltoglu et al., 2015; Tang et al., 2016). The economic burden of a single CRE infection 
on average can range from $22,484 to $66,031 for a hospital that contributes to additional 
length of hospital stay and cost per bed; $10,440 to $31,621 for third party payers that 
contributes to hospitalizations, drug treatments and additional tests costs; and $37,778 to 
$83,512 for a public health societal entities that constitutes direct and indirect 
productivity losses due to mortality costs and years of life lost–patient’s life expectancy 
(Bartsch et al., 2017). 
The literature review includes an overview on the background of the historic 
details of CRE, after which there is a detailed summary and the differences on the 
epidemiology of health care acquired CRE versus community-associated CRE. Studies 
on community-associated CRE in the United States were sparse. Global studies on 
community-associated CRE infections outside the United States were more abundant than 
community-associated CRE infections inside the United States. In addition, there were 
also multiple studies done on environmental exposure sources that could also be 
responsible for community-associated CRE infections. The literature review details are 
defined in Chapter 2. The independent variable set for this study was 4 geographical state 
locations. The first dependent variable set for this study was 4 clinical significant CRE 
characteristics (APIC, 2017). The second dependent variable set was 5 types of 
confirmed health care acquired Carbapenemase gene mechanisms reported to the CDC 
from four selected states (CDC, 2017a).  
In this study, I examined health care acquired and community-associated CRE 
clinically significant characteristics from four states Colorado, Illinois, West Virginia, 
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and South Dakota that report CRE data to their respective public health departments. In 
addition, I explored the 5 confirmed Carbapenemase gene mechanisms reported to the 
CDC from the same 4 selected states. 
Problem Statement 
What has been known in the past is that CRE cases began and have been confined 
to exist only in health care type facilities (Palmore & Henderson, 2014). Therefore, with 
recent reports along with certain literature that have supported CRE cases detected in 
community-associated outpatient type facilities in certain areas, there is confirmation that 
community-associated CRE infections are no longer nonexistent (Guh et al., 2015; 
Mortensen et al., 2016; Nordmann, 2014; Santos et al., 2017; Tang et al., 2016). What 
has not been well documented or specifically characterized is how CRE infections have 
started to emerge as community-associated in the United States. To explore the migration 
of CRE from health care type facilities only to also include community type settings it 
would be productive to examine the clinically significant characteristics from both 
settings.  
The dissemination of CRE infections contained within the health care type 
facilities have already been established as a serious public health threat, so for CRE to 
have the potential to spread and/or emerge to cause community-associated infections is 
cause for immediate and extensive action due to the high fatality rate and economic 
burden increasing exponentially from CRE (CDC, 2015a). As of 2016, if conditions do 
not improve to better assess AMR with special attention on CRE at any capacity, it will 
result in drug-resistant pathogens such as CRE to have the potential to increase 
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exponentially to 10 million cases with a cost of $100 trillion by the year 2050 (Robinson 
et al., 2016).  
Purpose of the Study 
My purpose in this study was to explore the prevalence of CRE infection cases 
that have been reported between the years 2013 thru 2016 as community-associated CRE 
cases and as health care acquired cases and compare the similar reported clinically 
significant CRE characteristics of organism identification, specimen source, medical 
facility type, and laboratory CRE gene mechanism detection method that have been 
reported to the respective state health departments in Colorado, Illinois, West Virginia, 
and South Dakota. I also explored the existence of 5 confirmed Carbapenemase gene 
mechanisms of Imipenemase (IMP), Verona Integron-encoded Metallo-beta-lactamase 
(VIM), Klebsiella pneumoniae Carbapenemase (KPC), New Delhi Metallo-beta-
lactamase (NDM), and Oxacillinase-48 (OXA-48) from the same 4 states of Colorado, 
Illinois, West Virginia, and South Dakota complied by the CDC as of 2017 from their 
Antimicrobial Resistant (AR) Laboratory Network to analyze the association of the 
confirmed Carbapenemase gene mechanism cases between the 4 states.   
Research Questions and Hypotheses 
Research Question 1: What is the association between CRE organism ID, 
specimen source, medical facility type, and laboratory gene mechanism detection method 
and geographical location (Colorado, Illinois, West Virginia, and South Dakota) from 
2013 to 2016? 
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H01: There is no association between CRE organism ID, specimen source, 
medical facility type, and laboratory gene mechanism detection method and geographical 
location (Colorado, Illinois, West Virginia, and South Dakota) from 2013 to 2016.  
H11: There is an association between CRE organism ID, specimen source, 
medical facility type, and laboratory gene mechanism detection method and geographical 
location (Colorado, Illinois, West Virginia, and South Dakota) from 2013 to 2016.  
Research Question 2: What is the association between the 5 types of confirmed 
health care acquired Carbapenemase gene mechanisms and geographical location 
(Colorado, Illinois, West Virginia, and South Dakota) reported to the CDC as of 2017? 
H02: There is no association between the 5 types of confirmed health care 
acquired Carbapenemase gene mechanisms and geographical location (Colorado, Illinois, 
West Virginia, and South Dakota) reported to the CDC as of 2017.  
H12: There is an association between the 5 types of confirmed health care 
acquired Carbapenemase gene mechanisms and geographical location (Colorado, Illinois, 
West Virginia, and South Dakota) reported to the CDC as of 2017. 
Theoretical Foundation  
AMR is an issue that encompasses multiple levels of complexity as well as 
ongoing increased public health threats (CDC, 2013a; Kaye & Pogue, 2015; Sanchez et 
al., 2013; van Duin & Doi, 2017). CRE is one of the most difficult parts of the whole 
AMR picture due to very limited to no antimicrobial choices for therapeutic treatment 
options, so with the recent emergence of CRE cases outside of health care type settings 
creating community-associated infections a state of alarm has heightened (CDC, 2015a). 
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The theoretical foundation most suited to tackle such an enormous and complex public 
health threat such as CRE would best be handled by the implemented concept of One 
Health (Solomon, 2017).  
The theoretical foundation is based on the fact that the health of humans, animals, 
and the environment intersect each other and should have optimum health through 
collaborative and cooperation efforts of multiple disciplines working together locally, 
nationally, and globally to help address the complex public health threat of AMR 
(Solomon, 2017; USDA/APHIS), n.d.). Because there is a pronounced level of concern 
for rapidly evolving and highly resistant bacteria such as CRE, the One Health theoretical 
foundation ideally concentrates on designs, implementations, evaluations, and execution 
of public health programs that are unique to combating AMR especially CRE (Solomon, 
2017), as well as an integrated surveillance framework (Queenan et al., 2016). The One 
Health concept acknowledges the challenges to combating AMR such as divisions within 
bureaucratic organizations, non-sharing of important health publication information, and 
different disciplines not using the same words or definitions to help with comprehension 
across health care, academic and scientific communities (Solomon, 2017). In Chapter 2, I 
provide additional detailed information on the history, prior implementations, and a 
conceptual framework diagram for the One Health theoretical foundation.  
Nature of the Study 
The nature of this study had a quantitative focus. The quantitative nonexperimental 
design for this retrospective secondary data analysis study used CRE data previously 
collected and compiled from four selected state public health departments, which 
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included Colorado, Illinois, West Virginia, and South Dakota. In addition, secondary 
CRE confirmed gene mechanisms data from the CDC was also explored.  
The independent variable set for this study for both research questions was selected 
states, which included 4 different geographical locations of Colorado, Illinois, West 
Virginia, and South Dakota. The first dependent variable set was clinically significant 
CRE characteristics which included organism ID, specimen source, medical facility type, 
and laboratory CRE gene mechanism detection methods (APIC, 2017). The second 
dependent variable set was confirmed health care acquired Carbapenemase gene 
mechanisms which will included IMP, VIM, KPC, NDM, and OXA-48 reported to the 
CDC as of 2017 (CDC, 2017a).  
Definition of Terms 
Carbapenem-resistant Enterobacteriaceae (CRE): Organisms that are 
nonsusceptible which is considered intermediate or resistant to the antibiotic class of 
carbapenems (CDC, 2015a). 
Carbapenem-producing Enterobacteriaceae (CPE): Organisms that have the 
ability to pass Carbapenemase, which are mobile genetic elements that transfer to 
organisms which will make them resistant (CDC, 2015a). 
Health care acquired infections: Infections caused by carbapenem resistant 
organisms patients have acquired within a health care setting also known as nosocomial 
infections when a hospital stay has been greater than 48 hours within a 2-week period or 
associated with a long-term care facility (Tang et al., 2016).  
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Community-associated infections: Infections caused by a Carbapenemase-
producing or by carbapenem resistant organisms acquired from a source outside of a 
health care facility setting (Tang et al., 2016).  
Outpatient care facilities: Facilities that administer any type of medical care 
outside of an in-patient hospital type environment such as but not limited to a doctor’s 
office, urgent care, dialysis center, and/or ambulatory surgical care center (CDPHE, 
2017). 
Assumptions 
I made several assumptions about this study along with the secondary data used. 
The secondary data collected by each selected state public department of health 
characteristic categories were not completely similar between each state and some lacked 
specific details. The CDC collected only confirmed molecular CRE mechanism data from 
health care facilities. Therefore, even though the secondary data reported was helpful, it 
lacked cohesiveness to establish a completely accurate representation of exact sources of 
CRE infection cases in the United States. 
Since reading through all of the literature from the literature review for this study 
antibiotic usage associated with animal and the environment sources could represent an 
important part to the emergence of community-associated CRE infections, but due to the 
fact that the state collected CRE data does not represent these specific source areas in the 
United States, it is not a provable hypothesis for this particular study (Lerner et al., 2013; 
Robinson et al., 2016) . This study can only bring about awareness to the possibility of 
alternative sources of CRE exposures from the extensive literature review. 
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Scope and Delimitations 
Due to the seriousness and public health threat CRE possess the scope of this 
study was limited to analyzing the current existence of CRE cases, both health care 
acquired and community-associated, and how they have been detected and reported in the 
United States. Populations excluded from the study were states that did not provide 
separated detailed information on clinically significant CRE characteristics. This study 
has limitations on understanding the relationship of how CRE could spread from outside 
health care facility sources not yet explored in the United States., which is why the 
literature review focus was broadened to include global, environmental and animal CRE 
cases that researchers have discovered in other countries. The 4 states selected and data 
as the focus for Research Question 1 and the CDC gene mechanisms data selected from 
the same 4 states for Research Question 2 for this study provided a reasonable inference 
on the generalizability of the results.  
Limitation 
For a retrospective study using secondary data, my attempt was to determine 
whether or not the independent variable had an effect on the dependent variables. The 
fundamental limitation for a study such as this had an apparent weakness due to groups 
not randomly selected or assigned as well as not being able to manipulate the independent 
variables. For this study the CRE data reporting to the respective state public health 
departments is still fairly new and is a work in progress when it deals to the consistency 
of the specific CRE data details that are reported from each state. The 4 states selected for 
Research Question 1 were the only states that had a category of community-associated 
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type CRE cases reported. For Research Question 2, the CDC confirmed CRE gene 
mechanisms have already been complied into categorized groups. The results for this 
study were limited to categories versus individual specifics on the community-associated 
CRE picture. Due to the lack of raw data on community-associate clinically significant 
CRE characteristics reported and the limited research studies on community-associated 
CRE studies in the United States. the scope of this study was limited. Even though the 
scope of this study had limitations it could be the catalyst needed for future studies.  
Significance 
In this study, I attempted to bring about awareness as to the possibilities of how 
community-associated CRE infections have emerged and increased in places such as 
outpatient care facilities in the United States, and the possible modes of transmission of 
community-associated CRE infections that are different compared to health care acquired 
CRE infections (Guh et al., 2015; Nordmann, 2014; Tang et al., 2016). To successfully 
control and reduce CRE infections albeit due to health care-acquired or community-
associated sources every entity dealing with health care and/or antibiotics has to be 
considered for the optimum health for all people, animals and the environment to work 
together at spreading and sharing valuable CRE information.  
In addition, new reporting regulations are needed for understanding the actual 
incidence rate, the actual prevalence rate, and specific clinical characteristics of all CRE 
infections to bring about a complete and positive social change for the public’s future 
health against CRE infections and possibly AMR in general. The potential positive social 
implications consist of improved public health by providing information to help in greatly 
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reducing the spread of CRE infections as well as a reduction to the overall economic 
burden of CRE infections, which is associated with the per capita cost of health care. 
These actions not only help in preserving the carbapenem class of antibiotics for when 
they are truly needed, but the most important positive social change will be in preserving 
the quality of life while saving future lives. 
Summary 
As a health care acquired infection CRE is a serious public health threat 
component to the AMR picture, so now that there are community-associated cases of 
CRE that have started to emerge in the United States. the health threat has heightened. 
There is limited knowledge on how community-associated CRE cases have emerged in 
the United States. I explored the prevalence of community-associated CRE cases as well 
as explored the existing confirmed Carbapenemase gene mechanism CRE cases and the 
threat these types of cases may impose. The knowledge gained from this study could 
provide future guidance in the reduction of all CRE cases; therefore, resulting in 
increased positive social change by providing awareness that brings about the reduction 
of the spread of CRE infections, the reduction in the economic burden of CRE, and 
preserve the carbapenem class of antibiotics for when they are truly needed preserving 
the quality of life while saving future lives. In Chapter 2, I provide specific details into 
the literature review search into the 2 major categories of CRE health care acquired and 
community-associated acquired as well as specific details on the selected theoretical 
foundation of One Health for this study. In addition, in Chapter 2, I provide an extensive 
background and historic details on CRE. 
14 
 
Chapter 2: Literature Review 
CRE infections have become a serious emerging public health threat (Bartsch et 
al., 2017; CDC, 2013a; Lee et al., 2016; Tängdén & Giske, 2015). The history of CRE 
cases started in and has been confined to only health care type facilities (Palmore & 
Henderson, 2014). CRE infections have one of the highest case-fatality rates, between 
40% to 50% for invasive types of infections such as bloodstream infections (CDC, 
2015a). The economic burden of a single CRE infection ranges in the tens of thousands 
(Bartsch et al., 2017). If there is no cohesive intervention to help decrease CRE as well as 
other AMR cases the economic burden can exponentially increase to trillions of dollars 
by the year 2050 (Robinson et al., 2016). 
Recent literature have supported CRE cases detected in community outpatient 
facilities in certain areas, which means community-associated CRE infections are no 
longer nonexistent (Guh et al., 2015; Mortensen et al., 2016; Nordmann, 2014; Santos et 
al., 2017; Tang et al., 2016). What has not been well documented and limited knowledge 
exist is how CRE infections have emerged into the community-associated category in the 
United States.  
My purpose in this study was to explore the prevalence of CRE infection cases 
that have been reported as community outpatient CRE cases and as health care acquired 
cases to see if there is an association of the specific CRE characteristics that are reported 
to the state health departments by states based on different geographical locations. This 
study also explored the strength of the association of existing confirmed Carbapenemase 
gene mechanism cases reported by health care facilities.  
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In addition attention was also needed on community-associated type exposures of 
CRE to explore other possible risk factors to improve the understanding of how CRE 
infections have emerged in places such as outpatient care facilities as well as possible 
modes of transmission of community-associated CRE infections that are different 
compared to health care acquired CRE infections (Guh et al., 2015; Nordmann, 2014; 
Tang et al., 2016). 
My main focus in Chapter 2 is the extensive literature search conducted for this 
study. Moreover, I continue with a focus on the history of the theoretical foundation One 
Health selected for this particular study as well as detailed background information on 
CRE. Furthermore, an exploration of potential CRE exposure risk factors was also 
highlighted for this study. 
Literature Search Strategy 
Chapter 2 encompasses detailed research approaches that I used for the literature 
review for this study. An extensive review of the literature I conducted included the 
understanding and clarifications on factors related to CRE incidence, prevalence, 
explanations, definitions, and theories. The majority of the literature review-concentrated 
search efforts involved studies on community acquired or associated CRE and CPE in the 
United States. I selected studies conducted on community acquired CRE and CPE outside 
the United States, which was a guide to extensively enhance the U.S. community 
acquired CRE literature search. 
Peer-reviewed journal articles and documents I accessed with the assistance of 
Walden’s library databases CINAHL, MEDLINE, ProQuest, PUBMED, and 
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ScienceDirect in addition to the search engine Google Scholar. Key search terms 
included the following: Carbapenem Resistant Enterobacteriaceae or (CRE), 
Carbapenemase Producing Enterobacteriaceae or (CPE), health care-acquired CRE 
infections, community-acquired CRE infections community-associated, CRE infections, 
CRE colonization, United States (U.S.), antibiotic resistance, CRE prevalence, CRE 
incidence, public health threat infections, One Health, and Antibiotic Resistant 
Theoretical Framework. Journal articles and documents were within the date ranges of 
2012 to 2018. An abbreviated summary of the search results is listed below in Table 1. In 
addition to peer-reviewed journals, government and state regulatory and reporting 
agencies such as the CDC, U.S. Department of Health and Human Services (HHS), I 
explored The Association for Professionals in Infection Control and Epidemiology 
(APIC) for guidelines, classifications, and regulations of CRE infections. I selected other 
recent publications if they were original works and vital and significant supportive 
literature. 
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Table 1 
 
Search Results Summary 
Database Search terms Peer-
reviewed 
selected 
Publication 
date 
Results 
Medline and 
CINAHL  
Carbapenem-resistant 
Enterobacteriaceae OR CRE 
 
No 2012 - 2017 6,840 
Medline and 
CINAHL 
Carbapenem-resistant 
Enterobacteriaceae OR CRE 
 
Yes 2012 - 2017 2,738 
Medline and 
CINAHL 
Carbapenem-resistant 
Enterobacteriaceae OR CRE 
AND infection(s) AND 
United States OR U.S. 
 
Yes 2012 - 2017 35 
Medline and 
CINAHL 
Carbapenem-resistant 
Enterobacteriaceae OR CRE 
AND colonization AND 
United States OR U.S. 
 
Yes 2012 - 2017 13 
Medline and 
CINAHL 
Carbapenem-resistant 
Enterobacteriaceae OR 
Carbapenemase-producing 
Enterobacteriaceae OR CRE OR 
CPE AND Community-acquired 
AND Infection(s) 
 
Yes 2012 - 2017 9 
ScienceDirect 
and 
Google Scholar 
Carbapenem-resistant 
Enterobacteriaceae OR CPE 
Community-associated CRE 
infection(s) 
 
No 2013 - 2017 815 
PUBMED Community-acquired 
Carbapenem-resistant 
Enterobacteriaceae Prevalence 
 
No 2012 - 2017 78 
ScienceDirect 
and Google 
Scholar 
Antibiotic-resistant Theoretical 
Framework AND 
One Health 
 
Yes 2012 - 2018 40 
 
18 
 
Theoretical Foundation 
The theoretical foundation selected for this study was One Health (OH), which is 
most appropriate amid the struggle to help reduce antibiotic resistance such as CRE 
(Solomon, 2017). One Health is viewed as a framework strategy targeted towards 
reducing risks of infectious diseases by embracing a collaborative approach on health 
concerns that interconnects human, animal and environment ever constant changes that 
present those risks (USDA/APHIS), n.d.). The concept that One Health promotes is that 
people, animals, and the environment can achieve optimum health through continuous 
joint efforts of all health professionals, scientists, organizations, and disciplines 
(Solomon, 2017). 
The history of One Health dates back to the middle of 1800 by a German scholar 
who also was a farmer named Rudolf Virchow (USDA/APHIS), n.d.). His philosophy 
was “Between animal and human medicine there is no dividing line – nor should there be. 
The object is different but the experience obtained constitutes the basis of all medicine” 
(USDA/APHIS, n.d., p.1). Nearly, 75 percent of emerging infectious diseases within the 
last 30 years among humans has had a connection to a zoonotic type diseases transmitted 
between animals to human (USDA/APHIS), n.d.). Examples of such animal to human 
zoonotic transmitted diseases are below listed in Table 2 (USDA/APHIS), n.d.). 
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Table 2 
 
Animal to Human Zoonotic Diseases 
Infectious diseases Infectious agents Source Year 
Human tuberculosis (TB) 20% cases Mycobacterium bovis Cattle Mid-1900s 
Human Brucellosis – 29,600 cases Mycobacterium bovis Cattle 1930-1941 
H5N1 virus Pathogenic avian 
Influenza A 
Birds 2006 
Swine flu Pathogenic type A 
Influenza 
Pigs 2012 
 
By 1980 Calvin Schwabe modernized the One Health theory by advocating for a 
human and veterinary unification approach to combat zoonotic diseases (USDA/APHIS), 
n.d.). By 2007, the American Medical Association (AMA) and the American Veterinary 
Medical Association (AVMA) put together an One Health Initiative (OHI) task force 
which included a host of world agencies such as but not limited to the World Health 
Organization (WHO), the Food and Agriculture Organization of the United Nations 
(FAO), and the world Organization for Animal Health (OIE) just name few 
collaborations (USDA/APHIS), n.d.).  
The Institute of Medicine (IOM) and the National Research Council (NRC) have 
advocated that human health is linked to animal health and the ecosystem health (Rubin 
et al., 2013). For the last 2 decades both the IOM and NRC have promoted publications 
and workshops addressing the shift to the implementation of One Health in order to 
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capture the potential threats that involve the connect of human, animal, and ecosystem 
risks (Rubin et al., 2013). 
One Health is the most appropriate framework essential for undertaking antibiotic 
resistance issues. Antibiotics that are used for humans and animals share some of the 
same molecules which makes transmission of resistance easier than realized between 
humans and animals directly or by way of the environment (Robinson et al., 2016). If 
collaborative efforts are not put forth by all respective public health entities to help tackle 
AMR such as CRE then drug-resistant pathogens have the potential to reach over 10 
million by the year 2050, which could cost the U.S. almost $100 trillion between now and 
2050 from food globalization, livestock movement, agriculture production, human travel, 
and AMR gene transfer (Robinson et al., 2016). 
A conceptual illustration of One Health surveillance framework is depicted below 
in figure 1 (Queenan et al., 2016). This framework expands the surveillance from just 
solely focused on human antibiotic usage and consumption data from hospitals and 
community to also the incorporation of the surveillance data sharing, usage, and 
consumption from animals, food and the environment (Queenan et al., 2016).    
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Figure 1. 
One Health Conceptual Framework 
 
Figure 1 depicts One Health surveillance framework that visually integrates the AMR and 
antimicrobial consumption for environment, humans, animals, and food. 
One Health is vital to the increasing profound crisis of AMR especially like CRE 
and to understand and apply the One Health approach to public health policies and 
programs which can help bring together different expertise across a broad field to include 
human, animal, and environment health will be extremely useful (Solomon, 2017). The 
implementation of One Health for some organizations, scientific entities, public health 
leaders and health care professionals have encountered some challenges and barriers such 
as varied jargon, bureaucratic divisions, and academic/scientific differences, but these 
challenges are easier to overcome than the increasing CRE situation in the United States. 
from unknown community sources (Solomon, 2017). 
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In this study I depict the urgency and importance of the implementation of One 
Health by exploring possible community-associated sources that can put the public’s 
health at risk for AMR such as CRE. The research questions help to show there is a lack 
of collaboration between entities that currently exist in order to determine how 
community-associated CRE is now a possibility in the United States. as well as help build 
upon existing theories of community-associated CRE.  
CRE Epidemiology 
Carbapenems are a class of beta-lactam antibiotics that includes meropenem, 
imipenem, ertapenem, and doripenem and are now considered a last resort treatment 
agent for highly resistant gram negative organisms in the Enterobacteriaceae family (Lee 
& Doi, 2014). Previously, carbapenems were considered highly effective broad-spectrum 
antimicrobials. Imipenem and meropenem were introduced in the 1980s, ertapenem was 
introduced in 2001, and doripenem is considered the latest member to be added to the 
carbapenem class (Perez & van Duin, 2013). The prevalence of CRE infections were 
extremely rare more than a decade ago and since their first appearance CRE infections 
have rapidly spread at an alarming rate (Rolain & Cornaglia, 2014).  
The first organism identified to exhibit a resistance characteristic to a carbapenem 
was Klebsiella pneumoniae and it was resistant to imipenem back in 2004 (Guh et al., 
2014). This resistance classification was named Klebsiella pneumoniae Carbapenemase 
(KPC) and some patients acquired KPC infections rapidly and steadily increased through 
to 2010. By 2006 Carbapenemase-producing organisms started to emerge due to the 
drastic increased use of carbapenems, which contributed to the classification of CRE 
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(Guh et al., 2014). The antibiotic resistance gene/plasmid mechanism that creates CRE is 
an element that is genetically mobile and has escalated the multidrug resistant bacteria 
categories (Kaye & Pogue, 2015). Due to the mobility quality of resistant gene 
mechanism new antibiotic resistance bacteria can emerge at any time from person to 
person and/or from nonhuman sources in the environment (Kaye & Pogue, 2015).  
Antibiotic resistance is the product of frequent widespread use of antibiotics 
appropriately and inappropriately without the proper dissemination of mobile resistant 
gene mechanisms, which is widely misunderstood by many health care and community 
care professionals (Guh et al., 2014). Since this factor has emerged it marked the end of 
just KPC existing and the beginning of the entire family of Enterobacteriaceae, which 
consists of all the gram negative bacteria being susceptible to inheriting a Carbapenemase 
resistant gene mechanism (Guh et al., 2014; Rolain & Cornaglia, 2014). 
The main mechanism that produces Carbapenemase to exist in certain organisms 
is known as b-Lactamase hydrolysis, which is broken down into Ambler classifications, 
of which are displayed in Table 3 the b-Lactamase Ambler classifications (Kaye & 
Pogue, 2015).  
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Table 3 
 
b-Lactamase Ambler Class Summary 
Ambler 
class 
b-Lactamases Enzyme example Typical organism producing 
the enzyme 
A Penicillinases KPC – Klebsiella 
pneumoniae 
Carbapenemase 
Klebsiella species, 
Escherichia coli, 
Enterobacter species 
 
 
B Metallo-b-Lactamases NDM – New 
Delhi Metallo-b-
lactamase 
IMP – 
Imipenemase 
VIM – Verona 
Integron-encoded 
Metallo-b-
lactamase 
 
Klebsiella pneumoniae, K. 
oxytoca, Escherichia coli, 
Enterobacter species 
 
 
C Cephalosporinases AmpC Enterobacter species, 
Citrobacter species, 
Pseudomonas aeruginosa 
 
D Oxacillinases OXA K. pneumoniae, E. coli, 
Acinetobacter baumannii 
 
 
KPC, NDM, IMP, VIM, AmpC, and OXA are examples of the designated resistant gene 
mechanisms; patients with bacterial infections caused by these Carbapenemase producers 
will be at a higher risk of morbidity and/or mortality. Identification of CRE gene 
mechanisms is an important step to the identification of which patients are infected with 
what mechanism in order to properly apply surveillance to keep transmission of gene 
transfer low (Kaye & Pogue, 2015; Rolain & Cornaglia, 2014).  
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There was a study conducted on antimicrobial resistant Klebsiella pneumoniae 
from surveillance data that totaled 3,132,354 cases collected from 1998 thru 2010 from a 
surveillance network and the results confirmed a significant increase of resistant to 
multiple antimicrobials (Sanchez et al., 2013). Starting at the end of the 20th century to 
the beginning of the 21st century AMR has grown into a significant health risk 
domestically especially when it involves gram-negative bacteria due to the increased 
resistance mechanisms, the spread of resistant strains from person to person, and/or from 
environmental sources. The threat of CRE infections and the imposed burden is 
increasing for the public health population in the United States (Kaye & Pogue, 2015; 
Sanchez et al., 2013). 
The CDC assigns different warning levels of threat specific hazards for infectious 
agents that have become a major concern and is highly suggested to be monitored and 
tracked (CDC, 2013a). There are 3 different warning level hazard categories starting with 
the lowest level of Concerning, the next level is Serious, and the highest level is Urgent. 
CRE has been assigned the Urgent warning hazard level due to having the status of very 
limited therapeutic options for treatment or completely untreatable infections involving 
patients within health care facilities (CDC, 2013a). The Urgent level warning is the 
highest consequence antibiotic-resistant threat and can have the potential ability to 
become widespread. As of 2013 in the United States. there has been an average of 9,000 
CRE infections with 600 deaths per year (CDC, 2013a). The concern that exist is that the 
CDC is only collecting and reporting on health care-acquired CRE confirmed specific 
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carbapenem mechanism cases and not CRE cases that are starting to emerge as 
community-associated cases (CDC, 2017a). 
Health care Acquired CRE Epidemiology 
A basic definition for health care acquired CRE are infections caused by 
carbapenem resistant organisms that patients have acquired only within a health care 
facility type setting (also known as nosocomial infections) when a hospital stay has been 
greater than 48 hours within a 2-week period or associated with a long-term care facility. 
CRE infections commonly poses a threat to patients exposed to high-risk infectious 
environments in a health care type setting (Tang et al., 2016). CRE generally exists in a 
patient as an infection, which causes a host of associated symptoms and/or disease to any 
part of the infected body site (CDC, 2015b). In addition, a patient can also be colonized 
with CRE, which means CRE exists in the body but is not causing symptoms or disease. 
CRE transmission to other patients and/or medical equipment presents the same risk to 
other patients whether CRE is classified as an infection or colonization (CDC, 2015b). 
An incidence rate of 2.93 per 100,000 population for CRE in the United States. would 
equate to about 9,418 infections, which is a sizeable economic burden of about $275 
million for hospitals if the severities of CRE infections are not fully comprehended and 
many health care professionals continue to be naïve to the ill effects of CRE infections 
(Bartsch et al., 2017). 
CRE infections have started to emerge in patients linked to community-associated 
type setting exposures without ever having been associated with a health care facility. A 
recent study supports that health care facilities’ infection control and prevention methods 
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have been inadequate in the spread and/or control of CRE (Thaden et al., 2014). The 
study results revealed that CRE infections went from (0.26 cases per 100,000 patient-
days) in 2008 to (1.4 cases per 100,000 patient-days) in 2012, which is almost a 5-fold 
increase (Thaden et al., 2014). CRE has varied in the scenarios and setting of spreading 
patterns, which could explain the migration to community-associated exposures. 
Community type exposures will definitely not have the specific control measures, 
regional support, or facility level infection control. Any facility administering medical 
care should employ an effective CRE prevention, control, and tracking strategies, which 
means all entities will have to work together because even health care facilities are 
finding CRE infections challenging to prevent, control, and track (Lee et al., 2016). 
Community-Associated CRE Epidemiology 
The basic definition for community-associated CRE is any infection caused by a 
Carbapenemase-producing or by carbapenem resistant organisms that patients have 
acquired outside of a health care facility type settings (Tang et al., 2016). Very few 
studies have been done to explore how CRE infections have started to emerge through 
community-associated transmission in the United States. One study conducted a 
comparison on urinary tract infections from community-onset health care type facilities 
and hospital type facilities and established that community-onset health care associated 
(CO-HCA) infections are a newly defined category for multi-drug resistant organism 
infections (Saltoglu et al., 2015). Not only are the characteristics of acquiring CRE 
changing, but the CRE transmission status is also changing from strictly nosocomial 
bacterial infections to also included community-associated bacterial infections 
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(Nordmann, 2014). Through the literature reviewed community-associated CRE cases 
started to take form by focusing on specific clinically significant CRE characteristics of 
the organism identified, the specimen source, the Carbapenemase gene mechanism 
detection method identified, and the medical facility type in which the patient was 
associated when identified to have CRE infectious (Guh et al., 2015; Kaye & Pogue, 
2015; Rolain & Cornaglia, 2014; Tang et al., 2016). One of the most valuable studies 
done was in Taiwan set the precedence for this study and that study looked at and 
determined that it was important to examine the clinically significance characteristics of 
pathogens, clinical sources, facility types, antibiotic resistance patterns, and 
demographics to determine that CRE infections originating from both health care 
acquired and community acquired facilities (Tang et al., 2016). The literature reviewed 
for community associated CRE has been categorized into 3 different sections: (1) 
domestic represents the few studies conducted in the United States.; (2) globally 
represents the broader studies conducted in countries other than the U.S.; and (3) 
environment represents a new transmission risk category for CRE. 
Domestic 
Community-associated CRE is on the rise in the United States. and not many 
studies exist that have explored the reasons as to how a strictly health care acquired 
infectious condition is now emerging into and can be acquired through community-
associated transmissions.  
When Methicillin-Resistant Staphylococcus aureus (MRSA) was first reported 
back in 1961 it to was acquired in only health care type facilities and it took some time to 
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determine that the resistance was the production of a horizontal gene transfer of the mecA 
gene (Stryjewski & Corey, 2014). By the early 1980’s Staphylococcus aureus had 
morphed into being resistant to multiple antimicrobials and was considered an epidemic 
until major efforts were implemented to truly track and prevent the spread of health care-
acquired MRSA (Stryjewski & Corey, 2014). By the 1990’s a new epidemic had emerged 
and was determined to be community-acquired MRSA, which was later confirmed to be 
transmitted from person to person through purulent skin infections amongst young people 
with no exposure to any health care facility (Stryjewski & Corey, 2014). Now the same 
scenario is happening with CRE infections, but under different circumstances. Until the 
transmission factors are completely understood for the emergence of community-
associated CRE infections the public’s health is at risk. 
One of the few studies conducted looking at community acquired CRE was a 
seven U.S. metropolitan areas study that suggested the CRE cases determined to be 
community acquired may have been from CRE cases that existed earlier when patients 
were hospitalized with prior infections from sterile sites and urine specimen sources and 
then later discharged to other medical care type facilities. The study further suggested 
that local efforts may need to be employed in order to help with the prevention and 
spread of CRE transmission (Guh et al., 2015). 
Thaden et al. (2014) provided evidence that 25 southeastern community hospitals 
in the United States. detected numerous CRE isolates from asymptomatic colonized 
patients and prospectively entered the CRE information into a centralized database from 
2008 to 2012, not only did this help keep track of the number of CRE cases but it also 
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helped determine the clinical characteristics of these specific CRE cases in order to help 
the 25 community hospitals respond to CRE in a proactive manner through dissemination 
of information (Thaden et al., 2014). 
After a CRE characterization study was conducted in a tri-state region in the 
United States. consisting of Ohio, Kentucky, & Indiana it recognized that although CRE 
has been primarily associated with transmission through health care type settings, 
community-acquired transmissions do exist and it will be important for future endeavors 
to understand this type of movement of resistance in order to respond to local and 
regional trends (Mortensen et al., 2016). Although few studies have been conducted on 
community-associated in the United States. the studies have offered some entry-level 
information on community-associated CRE, but overall knowledge remains limited and 
community-associated CRE is still not well defined or encompassing.  
Globally 
There have been many more studies conducted on community-associated CRE 
outside the U.S. Considering the sparse amount of literature for community-associated 
CRE in the United States. information regarding community-associated CRE globally 
was also reviewed in order to get a more in-depth prospective on risks, prevalence, 
incidence, and characteristics of CRE transmission through community associations. One 
study on community-associated CRE infections in Taiwan, suggested that the clinical 
characteristics were different for community-associated CRE from health care acquired 
CRE infections clinical characteristics; therefore, further larger studies are needed to 
study more clinical significance differences especially in the United States. (Tang et al., 
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2016). The most common characteristics for community acquired CRE cases discovered 
during the study conducted involved elderly females with UTIs whereas the health care 
acquired CRE cases involved more intra-abdominal infections and indwelling device 
infections (Tang et al., 2016). 
Zimmerman et al. (2013) researchers provided compelling evidence from an 
investigative study conducted in Israel that suggested an initial diagnosis of a positive 
CRE culture could have a mean time of 387 days to proven CRE negative. One hundred 
thirty-seven hospitalized patient records with positive CRE cultures from 2009 to 2010 
were subjects selected for the study. Twenty-one of the 137 patients were initially 
diagnosed CRE positive as an outpatient, so not all of the positive CRE cases originated 
in the hospital. Many factors that revealed the mean time of 387 days of CRE carriage 
included repeat hospitalizations, seriousness of the cofounding illnesses, staff exposure 
time to the infected patients, and the lack of monitoring antimicrobial usage of patients 
discharged (Zimmerman et al., 2013). The carriage time of more than a year from CRE 
positive to CRE negative could have significant influence on the exponential rise and 
spread of CRE to the community setting. In addition, another recent prospective 
observational study illustrated an alarming high prevalence of community associated 
multi-drug resistant organisms (MDRO) colonized in East India patients and highlighted 
the fact that the prevention of antibiotic misuse in the community can help minimize this 
critical problem (Thacker et al., 2014). 
A more recent study reported that an outpatient admitted to a Portuguese hospital 
had a community associated CRE infection, which was acquired through possibly 
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horizontal gene transfer (Santos et al., 2017). Horizontal gene transfer involves CRE 
strains that have moved between inpatients and outpatients through human gut 
colonization and carried beyond the hospital environment. This was evidence that 
improved containment measures for antibiotic resistant stewardship are needed for both 
inside and outside medical facilities due to evidence of inter-institutional gene transfer 
from hospital to dissemination into the community (Santos et al., 2017). 
A study conducted in 3 Lebanon medical facilities tried to determine if there were 
comparative data differences between community-acquired infections (CAI) and health 
care associated infections (HAI) (Dabar et al., 2015). The characteristics examined were 
population characteristics such as age comorbidities like diabetes, cirrhosis, & cancer; 
and heterogeneity characteristics such as microbial infection organism, site of the 
infection, and microbial resistance gene pattern (Dabar et al., 2015). The type of 
infections determined if there were significant differences between the 2 groups CAI and 
HAI concluded in the following results. Respiratory tract infections represented the most 
common infection for both groups, but very small significance in characteristic 
differences between the 2 groups (Dabar et al., 2015). Urinary tract infections (UTIs) 
represented a fairly good number in the HAI group with an even higher number for the 
CAI group; moreover, the study concluded that UTIs could be the explanation of factors 
causing resistant bacteria to emerge and increase within the community due to the usage 
of antibiotics not being monitored properly and not tracking if the patient CRE UTI 
infection actually resulted as negative (Dabar et al., 2015). 
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A retrospective matched case-control parallel study conducted in a hospital in 
Central South China where carbapenem resistant Escherichia coli (CREC) specifically 
targeted to examine the risk factors and scarcity of data to the increased emergence and 
spread of CREC in health care associated facilities, which has become a serious problem 
in Chinese hospitals (Meng et al., 2017). The multivariate conditional logistic regression 
analysis helped conclude several risk factors such as prior hospital stays are highly 
associated with health care acquired CREC; carbapenem exposure and urinary tract 
disease along with additional comorbidities such as anemia and/or high blood pressure 
were regarded as important co-risk factors as well. It was theorized that the environment 
encompasses a reservoir that is limitless when it comes to AMR genes and more patients 
are carriers of antibiotic resistant organisms (Meng et al., 2017). It was determined and 
highly suggested that implementation of infection control processes and antibiotic 
stewardship across all health care type entities could greatly help with the reduction of 
the emergence and spread of CREC (Meng et al., 2017). 
A prospective observational study done involving two Korean community 
hospitals supports the theory that highly extra-intestinal pathogenic Escherichia coli 
(ExPEC) which is an extended-spectrum-b-lactamase producer isolated from many UTIs 
in health care facilities was the resistant suspect gene that caused the drug resistant 
organism to migrate to community facilities. This study highly suggests that UTIs are a 
major concern for community onset bacterial resistant infections and should not be 
ignored especially for the asymptomatic carriage individuals who are healthy without 
prior exposure to antibiotics (Kim et al., 2017). 
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Tängdén & Giske (2015) expressed concerns that the possibility of untreatable 
community acquired urinary tract and bacteremia infections caused by carbapenem 
resistant E. coli are on the rise, which is a major public health threat. All medical 
professionals and all medical facilities should be aware of this threat as well as be aware 
of how to appropriately treat and manage patients with true CRE infection and those 
patients that are just colonized due to the rapid global dissemination of Carbapenemase 
(Tängdén & Giske, 2015).  
Lastly, a comprehensive analysis was conducted on Carbapenemase producing 
Enterobacteriaceae (CPE), non-nosocomial infection, epidemiological characteristic 
features in Spain (Palacios-Baena et al., 2016). The breakdown of reservoirs for CPE 
non-nosocomial infections were colonized patients from nursing homes and acute care 
hospitals contributing to the frequent lower urinary tract infections into the community 
(Palacios-Baena et al., 2016). 
Overall the global studies reviewed helped established and highlighted that there 
are many opportunities for CRE to spread whether initially acquired in a health care type 
setting or not will eventually find a way out into the community setting albeit from prior 
CRE infections not completely treated, improper use of antibiotics, no communication of 
current or past patient medical history of CRE infections. 
Environmental 
Upon review of the literature it was revealed in global studies that a possible 
transmission mode for CRE could be factors related to the environment. After this 
knowledge was uncovered in the literature it was also explored as to how the 
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environment would be a mode of transportation for CRE exposure risk. Multiple studies 
were reviewed below to highlight just what some of those environmental factors could 
include. 
Palmore & Henderson (2013) researchers addressed the fact that asymptomatic 
carriers can easily transmit resistant gram-negative pathogens to the environment in 
varying degrees. Identifying colonized patients is extremely important for the reduction 
of spreading factor of infections (Palmore & Henderson, 2013). If colonized 
asymptomatic carriers of CRE are an unrelenting challenge for health care facilities, then 
having those same carriers out in community-associated type settings will make it 
extremely difficult for detection and surveillance measures for CRE infections. This 
study also theorized that sink drains and ventilators used in the presences of infected 
patients could possibly be a source of transmission of resistant pathogens if not properly 
decontaminated (Palmore & Henderson, 2013). 
Abraham, Wong, Turnidge, Johnson, and Trott (2014) researchers hypothesized that 
the close relationship between humans and their pets could contribute to the expansion of 
Carbapenemase-producing bacteria by way of cross-species transmission, which would 
be considered an unnoticed source for multi-drug resistant gram-negative bacteria to 
become community associated. Organisms such as Escherichia coli that carry the NDM-1 
and/or the OXA-48 genes and OXA-48 Klebsiella pneumoniae have been isolated from 
companion animals with clinical infections. Laboratories that deal only with veterinary 
diagnostic medicine will not have the necessary knowledge to diagnosis or provide 
treatment for animals that have CRE infections due to the fact that carbapenems are not a 
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registered antimicrobial for animals in the United States. It has been documented that on 
rare occasions a veterinarian has used carbapenems as an off-label treatment for dogs 
with multi-drug resistant UTIs (Abraham et al., 2014). 
Guerra, Fischer, and Helmuth (2014) researchers presented a study that proposed the 
presence of gram-negative organisms that carry the Carbapenemase genes involving food 
producing sources like livestock; wildlife and seafood in the environment have been 
exhibited, which makes sense because of the relationship of gram-negative organisms and 
soil along with irrigation water sources. The actual prevalence of zoonotic bacteria that 
carry Carbapenemase genes are not known, which is a problem because food sources 
along with other animal sources are a huge concern. With recent knowledge of food 
sources at risk for environmental CRE exposures there has not been as of yet any official 
reported retail meat or other food items possibly contaminated with CRE organisms 
through environmental exposures only observational reports, which makes the situation a 
reality (Guerra et al., 2014). 
Carbapenemase-producing Salmonella species were isolated from pig sources at a 
swine farm in Germany. Salmonella species with the Carbapenemase-producing gene 
were isolated from beef and buffalo sources in India and CRE E. coli was isolated from 
oysters and shrimps from pond water sources in Brazil. The authors also proposed the 
existence of CRE in companion animals of which Carbapenemase-producing OXA-23 
Acinetobacter species was isolated from 20 horses that required hospitalization in 
Belgium and NDM-1 producing Escherichia coli was isolated from canines and felines 
recently in the United States. The authors theorized that the abusive behavior of 
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antimicrobial medicine usage by humans and possibly the present of hospital waste is the 
link to the environment presence of CRE (Guerra et al., 2014). 
Antibiotic resistance and food safety have already become a reality and challenge 
in the United States. Due to improper use of antibiotics in humans and what is termed as 
food animals (CDC, 2017b). A foodborne illness is normally a self-limiting condition, 
but if the illness is a severe case that requires antibiotics the ability to treat if the bacteria 
is antibiotic resistant will be a challenge. A limited treatment option for the patient not 
only puts that patient at a high mortality risk, but the public health threat has increased 
(CDC, 2017b). 
Summary 
In summary, health care acquired CRE in the United States has already been 
established as a public health threat, an enormous economic burden, and has extremely 
high mortality rates (Bartsch et al., 2017; CDC, 2013a; Lee et al., 2016; Tängdén & 
Giske, 2015). CRE has started to emerge outside of health care type facilities and into 
community type settings in the United States. And little research has been done to 
explore how CRE infections have emerged into being community-associated type 
transmissions in the United States. Literature was reviewed from multiple global sources 
to explore possible factors as to how CRE transmission can migrate from health care-
acquired to community-associated and what possible clinical significant CRE 
characteristics are common and/or different than health care acquired CRE transmissions 
(Guh et al., 2015; Mortensen et al., 2016; Nordmann, 2014; Santos et al., 2017; Tang et 
al., 2016).  
38 
 
My purpose for this study was to examine the prevalence of what already exists in 
the United States on community-associated CRE infections as well as health care-
acquired CRE infections and compare the differences of the CRE characteristics. The 
theoretical framework selected for this study was One Health, which embodies that 
optimum health be established for people, animals, and the environment (Solomon, 
2017). No one entity has the capability to successfully improve population health alone 
especially when dealing with CRE, which is why a collaborative effort is needed across 
multiple health care and community, care medical systems. 
A brief history on CRE epidemiology was provided to better understand the origin 
of carbapenems and on how CRE came to exist (Guh et al., 2014; Rolain & Cornaglia, 
2014). Epidemiology factors were provided on health care acquired CRE and 
community-associated CRE. Community-associated CRE reviewed literature was further 
broken down into 3 different categories domestic, global, and environmental. The 
community-associated CRE literature domestically embodied the U.S., but only a few 
studies were conducted. This study has added to the small list of existing studies 
conducted in the United States. while also providing a catalyst for other similar future 
studies. Although out of scope for this study literature review on environmental sources 
of CRE transmission was quite compelling and introduced factors that exist but have not 
been explored in the United States. before, which presents another facet on the 
emergence of CRE in the United States. Chapter 3 provides details on the population 
selected, the methodology, and data analysis plan that was used to determine whether or 
not an association exists between clinically significant CRE characteristics and whether 
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or not an association exist between confirmed health care acquired Carbapenemase gene 
mechanism between 4 selected states. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
Chapter 3: Research Methodology 
Introduction 
My purpose in this study was to explore the prevalence of CRE infection cases 
that have been reported during 2013 to 2016 as community-associated CRE cases and as 
health care acquired CRE cases that have similar clinically significant CRE 
characteristics reported to the selected 4 respective state health departments to determine 
whether there was an association. In this study, I also explored the existence of 5 
different confirmed Carbapenemase gene mechanisms compiled by the CDC between 
2016 and 2017 from the selected 4 states to determine whether there is an association 
between those particular 5 confirmed Carbapenemase gene mechanisms and the 4 
selected states.  
Chapter 3 is an overview of the research design and rationale for the study. In this 
chapter, I cover details on the sample selected, the population targeted, the sampling 
procedures, and the data collection. I state the dependent and independent variables along 
with selected data analyses plan. The end of the chapter entails a discussion of the 
possible threats to the internal and external validity along with the ethical procedures 
finally followed by a summary. 
Research Design and Rationale 
The research design that I selected was a retrospective causal-comparative design I to 
explore an occurrence that already exists. This quantitative nonexperimental retrospective 
process was the most appropriate design selection for this study to look back at secondary 
data to see whether the dependent variables were affected by the independent variables. 
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The selected research design assists with the exploration of the prevalence of community-
associated and health care acquired CRE cases with similar clinically significant 
characteristics by using nonprobability sampling secondary data from the public health 
departments from 4 selected states and confirmed Carbapenemase gene mechanisms from 
the same 4 selected states and compiled by the CDC from the AR lab network. There was 
1 independent variable, group of states, in the United States, for both research questions 
which included Colorado, Illinois, West Virginia, and South Dakota. There were 2 
different dependent variable sets for this study. The first dependent variable set for this 
study was 4 clinically significant CRE characteristics, which included organism ID, 
specimen source, medical facility type, and laboratory gene mechanism detection 
methods (APIC, 2017). The second dependent variable set was confirmed health care 
acquired Carbapenemase gene mechanisms, which included 5 groups IMP, VIM, KPC, 
NDM, and OXA-48 reported to the CDC as of 2017 (CDC, 2017a). The variables groups 
for the study cannot be manipulated, which presented some design weaknesses by not 
being able to randomly select specific groups, but is a way to link present events to past 
events (Creswell, 2009). Studies on community-associated CRE are sparse in the United 
States and this design choice helped to bring about awareness and helped advance the 
knowledge of the origin of community-associated CRE infections by providing valuable 
information on the association that exists between the 4 states that reported community-
associated and health care acquired CRE infections from 2013 to 2017 for future studies 
to build upon. 
42 
 
Research Questions and Hypotheses 
Research Question 1: What is the association between CRE organism ID, 
specimen source, medical facility type, and laboratory gene mechanism detection method 
and geographic location (Colorado, Illinois, West Virginia, and South Dakota) from 2013 
to 2016? 
H01: There is no association between CRE organism ID, specimen source, 
medical facility type, and laboratory gene mechanism detection methods and geographic 
location (Colorado, Illinois, West Virginia, and South Dakota) from 2013 to 2016. 
H11: There is an association between CRE organism ID, specimen source, 
medical facility type, and laboratory gene mechanism detection methods and geographic 
location (Colorado, Illinois, West Virginia, and South Dakota) from 2013 to 2016. 
Research Question 2: What is the association between the 5 types of confirmed 
health care acquired Carbapenemase gene mechanisms and geographic location 
(Colorado, Illinois, West Virginia, and South Dakota) reported to the CDC as of 2017? 
H02: There is no association between the 5 types of confirmed health care 
acquired Carbapenemase gene mechanisms and geographic location (Colorado, Illinois, 
West Virginia, and South Dakota) reported to the CDC as of 2017? 
H12: There is an association between the 5 types of confirmed health care 
acquired Carbapenemase gene mechanisms and geographic location (Colorado, Illinois, 
West Virginia, and South Dakota) reported to the CDC as of 2017? 
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Methodology 
Setting and Sample 
Data that I used for this study to address the first research question were from 
departments of health from 4 selected individual states that implemented require 
statewide reporting of CRE information. Although each state had different CRE 
informational reporting requirements a summary list of which states reported CRE 
information to their respective departments of health was compiled in a summary report 
by the (APIC, 2017). The states selected for this study with reported CRE epidemiology 
information included Colorado, Illinois, West Virginia, and South Dakota (CDPHE-2013, 
2017; CDPHE-2014, 2017; CDPHE-2015, 2017; IDPH-2014, 2017; IDPH-2015, 2017; 
SDDOH, 2017; WVDHHR-2014, 2017; WVDHHR-2015, 2017; WVDHHR-2016, 
2017). I selected these particular 4 states due to the similarities in the clinically 
significant CRE characteristics information that was reported to each state health 
department as well as the population size. Each selected state recently started reporting 
CRE data as early as 2013 with the latest reports up to 2016. One of the most important 
factors as to why these 4 states were selected is that all had similar variables reported, 
which made it a little less problematic when it came to analyzing the independent and 
dependent variables. Refer to table 4 for the similar CRE characteristics reported from 
each state that were relevant to this study. 
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Table 4 
 
CRE Clinically Significant Characteristics Reported Per Selected State 
CRE Characteristics Selected States 
 Colorado Illinois West Virginia South Dakota 
Organisms Ö Ö Ö Ö 
Specimen Sources Ö Ö Ö Ö 
Facility Types Ö Ö Ö Ö 
Lab gene Detection Methods Ö Ö Ö Ö 
 
The Colorado Department of Public Health and Environment (CDPHE) 
implemented a regulatory action for laboratories to report CRE information to the state 
within 7 days of CRE confirmation using the state’s electronic disease reporting system 
effective as of November 30th 2012 (APIC, 2017). Colorado CRE data reported in 
January thru December of 2013, 2014, and 2015 to the CDPHE were used for the data 
analysis for this study (CDPHE-2013, 2017; CDPHE-2014, 2017; CDPHE-2015, 2017). 
The Illinois Department of Public Health (IDPH) implemented a regulatory action that 
required laboratories and health care facilities to report the first CRE isolate from a 
patient within 7 days of the finalization of the CRE test result using the state’s 
Extensively Drug-Resistant Organism (XDRO) registry effective as of November 1st 
2013 (APIC, 2017). Illinois CRE data reported in January thru December of 2014 and 
2015 were used for the data analysis for this study (IDPH-2014, 2017; IDPH-2015, 
2017). The West Virginia Bureau for Public Health implemented a protocol requirement 
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that all laboratories test results that are positive for CRE be reported to the state using the 
West Virginia Electronic Disease Surveillance System CRE Report Form effective as of 
August 12th 2013 (APIC, 2017). West Virginia CRE data reported in January thru 
December of 2014, 2015, and 2016 were used for the data analysis for this study 
(WVDHHR-2014, 2017; WVDHHR-2015, 2017; WVDHHR-2016, 2017). Lastly, the 
South Dakota Department of Health updated their list of mandatory reportable disease list 
to include CRE effective as of July 1st 2013 and any CRE result is to be reported within 3 
days of confirmation (APIC, 2017). South Dakota CRE data reported in July thru 
December of 2013 and January thru December of 2014, 2015, and 2016 were used for the 
data analysis for this study (SDDOH, 2017). 
Data that I used for this study to address the second research question was from 
the CDC, which included the following 5 different confirmed Carbapenemase gene 
mechanisms of IMP, VIM, KPC, NDM, and OXA-48 collected from health care facilities 
in the 4 selected states of Colorado, Illinois, West Virginia, and South Dakota between 
2016 to 2017 (CDC, 2017a). The CDC just recently established an Antibiotic Resistance 
Laboratory Network (AR Lab Network) in 2016 and received additional funding to do 
confirmatory testing for specific CRE gene mechanisms. The AR lab network mainly 
tracks changes in antibiotic resistances in order to help identify and respond to outbreaks 
(CDC, 2017a). The network receives antibiotic resistance information on 50 states, 5 
cities, and Puerto Rico through 7 regional laboratories. The 7 regional labs are located in 
Maryland, Minnesota, New York, Tennessee, Texas, Washington, and Wisconsin. The 
AR lab network chain of process involves the local health care facility lab sending a 
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confirmed CRE case sample to the respective public health department lab then the 
public health department lab will send the CRE case sample to the regional lab, which 
will be tested again to confirm the CRE gene mechanism and finally the information is 
sent to the CDC to compile (CDC, 2017a). 
The CDC started collecting CRE gene mechanisms data in 2016, and CRE gene 
mechanism data are available from 2016 to 2017. Currently, the CDC only compiles 5 of 
the many different types of CRE gene mechanisms that exist, which are IMP, VIM, KPC, 
NDM, and OXA-48 (CDC, 2017a). The AR lab network is a reliable tool for tracking 
specific CRE gene mechanisms in health care facilities, but recently CRE cases are 
emerging outside of health care facilities. The CDC confirmed CRE cases are only part of 
the crucial CRE picture with community-associated CRE cases being missed, which may 
result in additional CRE gene mechanism types being undetected. 
Population 
The limited demographic information available on the 4 selected states’ population 
considered for the first research question is located below in Table 5. In Table 5 
information includes the total number of CRE cases collected between 2013 to 2016, 
sorted by state, gender, and median patient age that were reported with a CRE infection. 
This information provided an overall view of how patients were affected with CRE. Also 
available on the 4 selected states were the reported regions for CRE and population size, 
which can be found below in table 6. The public health regions are the actual regions in 
which CRE cases were reported as well as the latest population census and the most 
recent estimated census information. Table 6 also provided a view of the total number of 
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individuals that could potentially be at exposed risk to community-associated CRE 
infections if health professionals are not educated and/or informed on CRE. 
Table 5  
 
Select States’ Individual Available Demographics 
 
Selected States CRE Patient Demographic Information 
2013 to 2016 
Characteristics                            States 
  Colorado  Illinois  West Virginia  South Dakota 
Patient’s Median Age   67  65  68  69 
         
Sex         
Female  300  1158  300  75 
Male  238  1110  149  70 
Patient Totals  538  2268  449  145 
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Table 6 
 
Selected States CRE Reported Regions and Population Size  
State  Public Health Regions  2010 
Census 
Population 
 2017 
Estimated 
Population 
Colorado  Denver, Metropolitan 
Northeast, Southeast, & Western  
Slope 
 5,029,196  5,607,145 
       
Illinois  City of Chicago, West Chicago, 
Rockford, Peoria, Champaign, 
Edwardsville, Marion, & Unknown 
 12,830,632  12,802,023 
       
West 
Virginia 
 Southern, Central, Eastern, Western, 
Northwestern, Northeastern 
 1,852,994  1,815,857 
       
South 
Dakota 
 Pennington, Oglala Lakota, Corson,  
Ziebach, Dewey, Walworth, McPherson, 
Edmunds, Faulk, Brown, Spink, Beadle, 
Clark, Codington, Hamlin, Roberts, 
Grant, Brookings, Tripp, Brule, Charles 
Mix, Davison, Minnehaha, Turner, 
Lincoln, Yankton, Clay, Union 
 814,180  869,666 
 
As mentioned previously the information on the data selected to address the second 
research question was compiled gene mechanism confirmed CRE cases from patients 
with health care acquired CRE cases from the 4 selected states. 
Sample and Sampling Procedure 
The sampling strategy of nonprobability purposive was the most appropriate for 
this study due to the exploratory research when trying to determine if an issue exists 
when limited amount of research currently exists. The sample population selected focuses 
on the characteristics of interest which are both health care acquired and community-
associated CRE cases (Frankfort-Nachmias & Nachmias, 2007). The inclusion criteria 
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were specific distinct individual categorized clinically significant CRE characteristics 
reported to a particular state’s department of health that was used for comparison as listed 
above in table 4. The exclusion criteria included no distinct individual clinically 
significant CRE characteristic of medical facility type reported to the state’s department 
of health and/or state not reporting CRE results at any capacity. The CDC compiled list 
of confirmed CRE gene mechanisms for the second research question was not an 
exhaustive population list because currently only health care facilities are reporting their 
confirmed CRE cases to the CDC and no other types of facilities, which was also under 
the sampling strategy of non-probability. All of the CDC collected confirmed CRE gene 
mechanisms of IMP, VIM, KPC, NDM, and OXA-48 compiled data was an inclusion 
factor with no exclusion factors in order to explore an association of this newly collected 
data. 
Based on a retrospective design type analysis to address both research questions 
G*Power software was used to determine the sample size, effect size, and power (Bruin, 
2006). The statistical test of choice for both research questions was the Goodman and 
Kruskal’s lambda measurement of association analysis after each research question and 
measurement of variables passed the 2 required assumptions (Laerd, 2016). The first 
assumption requirement for Goodman and Kruskal’s lambda states there should be 1 
dependent variable and 1 independent variable. Both dependent and independent 
variables were on a nominal scale and each variable contained multiple categories such as 
gender has 2 categories or profession can have 5 categories. An ordinal scale variable 
could be used with the Goodman and Kruskal’s lambda test, but the ordinal status will 
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not remain after the test has been implemented; therefore, it is recommended to select an 
alternative test such as Goodman and Kruskal’s gamma if an ordinal nature is needed 
throughout testing (Laerd, 2016). The second assumption requirement for Goodman and 
Kruskal’s lambda states that there should be no relationship between observations within 
the groups or between the groups which would constitute independence of observations 
(Laerd, 2016) 
For the first research question implementing a measure of association between 
categorical variables using Goodman and Kruskal’s lambda was the most appropriate 
analysis having an alpha level of 0.05, an effect size of 0.3, power of 0.95, and a 
noncentrality parameter l of 19.80 would require a sample size of at least 220. For the 
second research question also implementing Goodman and Kruskal’s lambda also was 
the most appropriate analysis and it would have the same of an alpha level of 0.05, an 
effect size of 0.3, power of 0.95, and a noncentrality parameter l of 19.80 would require 
a sample size of at least 220 (Bruin, 2006). For this study there were no other studies in 
the literature review that revealed effect sizes or power predetermined or determined in 
past studies. This was definitely the first study of its kind and the logic behind the effect 
size and alpha calculated using G*Power was strictly to get the appropriate samples size 
to yield at least a power of 0.95 
Data Collection 
This retrospective study used secondary archival CRE epidemiology summary 
data from 4 individual state departments of health from Colorado, Illinois, West Virginia, 
and South Dakota. Access to each state’s secondary data sets were available on each 
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respective website located in their epidemiological summary reports. The Colorado 
Department of public Health and Environment decided that a population-based 
surveillance was needed in order to capture the incidence of carbapenem resistance from 
residents with certain CRE bacterial infection cases over time from 5 different counties 
for an overall evaluation and this collection of data started in November 2013 to 
December 2015. The patient data originally collected for the surveillance report included 
sex, age, organisms, specimen source, facility type, antibiotic susceptibility testing, and 
PCR testing for Carbapenemase (CDPHE, 2018).   
The Illinois Department of Public Health realized that CRE were appearing on 
their extensively drug-resistant organisms (XDRO’s) registry, so of the culture 
acquisition dated from November 1, 2013 to December 31, 2015 retrieved representing 
eight different regions in order to evaluate these CRE infections with little to no treatment 
options. The original data collected for the surveillance report included sex, age, 
organism, culture type, facility type, lab detection method, and mechanism of resistance 
(IDPH-2014, 2017; IDPH-2015, 2017). 
The West Virginia Department of Health & Human Resources recognized that 
CRE was developing as community-associated in addition to health care-associated cases 
and decided in 2013 to make it a requirement to report all confirmed CRE cases. The 
surveillance reports however only contained data collected from 2014 to 2016 from 6 
regional areas. The original data collected included sex, age, race, culture type, organism, 
specimen source, facility type, and mechanism of resistance (WVDHHR-2014, 2017; 
WVDHHR-2015, 2017; WVDHHR-2016, 2017). 
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The South Dakota Department of Health recognized an outbreak of CRE in the 
northeast region of their state, which put their state on high alert in 2013 to implement a 
policy to CRE to the reportable disease list. The current surveillance report included data 
reported from 2013 to 2016. The original data collected from multiple regions include 
sex, age, race, patient CRE history, specimen source, organisms, mechanism of 
resistance, facility type, lab detection method, and Carbapenemase producers (SDDOH), 
2017). 
This retrospective study used secondary archival data of confirmed health care 
acquired CRE gene mechanisms collected by the CDC from 2016 to 2017 for the 4 
selected states of Colorado, Illinois, West Virginia, and South Dakota. Details on the 
selected clinically significant characteristic CRE variables and the CDC confirmed gene 
mechanisms that were of value for the data analysis from the selected populations to 
answer both research questions are listed in table 7 below. 
Table 7 
 
Characteristics from the Original Data Collection 
Variable Type Variable Name Data Source Measurement 
Independent Geographical Location Demographics Nominal 
Dependent Organism Clinical Nominal 
Dependent Specimen Source Clinical Nominal 
Dependent Facility Type Clinical Nominal 
Dependent Lab Detection Method Clinical Nominal 
Dependent Carbapenemase Gene Mechanisms Clinical Nominal 
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Table 8  
 
Data details 
Data Implementation Details 
Variable Type Variable Name Code Naming List 
 
Independent    
(RQ1 & RQ2) 
Four Selected States Colorado, Illinois, West Virginia, & South 
Dakota 
 
Dependent-1 
(RQ1) 
Organism IDs E. coli, K. pneumoniae, K. oxytoca, E. 
aerogenes, E. cloacae, & Enterobacter 
species 
 
Dependent-2 
(RQ1) 
Specimen Source Urine, Blood, Wound, Rectal, Respiratory, 
& Intra-abdominal 
 
Dependent-3 
(RQ1) 
Medical Facility Type Acute Care, LTACH, LTCF, & Outpatient 
 
Dependent-4 
(RQ1) 
Lab Gene Detection Method Molecular Testing, Phenotypic Testing, 
Antibiotic Susceptibility Testing 
 
Dependent-5 
(RQ2) 
Confirmed CRE Gene 
Mechanisms  
IMP, VIM, KPC, NDM, & OXA-48 
 
 
Dependent and Independent Variables 
The independent variable group to address both research questions was the 4 
selected geographical location consisting of Colorado, Illinois, West Virginia, and South 
Dakota. The dependent variable set for Research Question 1 was the clinically significant 
CRE characteristic group consisting of organism IDs, specimen sources, medical facility 
types, and lab gene detection methods, see Table 8 above for details (long-term acute care 
hospital – LTACH & long-term care facility – LTCF). For Research Question 2 the 
dependent variable set was the 5 types of confirmed health care acquired Carbapenemase 
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mechanisms compiled by the CDC that will include IMP, VIM, KPC, NDM, and OXA-
48, see Table 8 above for details. 
Data Analyses Plan  
SPSS was the statistical software used to perform the analyses for both Research 
Question 1 and Research Question 2. Since both research questions and variable 
measurements passed both stated assumptions the Goodman and Kruskal’s lambda was 
be the most appropriate statistical analysis to answer both research questions (Laerd, 
2016). It helped determined whether or not there was associations between the nominal 
variables that were statistically significant while distinguishing between the independent 
variable and the dependent variable. An asymmetrical statistic such as lambda measured 
the strength of association and also the proportional reduction in predictive error (PRE) 
(Laerd, 2016). The original coding of the data was retained for this study. The initial step 
to preparing the data required extraction from the surveillance reports and importation 
into an excel file. The cleaning process included but was not limited to editing the data in 
order to address missing data, deletion of data, and possible outliers just to name a few 
probable errors that were encountered. A descriptive analysis in the form of frequencies 
was generated for all variables to ensure the number of records were accurate prior to 
analysis. 
RQ1: What is the association between CRE organism ID, specimen source, 
medical facility type, and laboratory gene mechanism detection method and geographical 
location (Colorado, Illinois, West Virginia, and South Dakota) from 2013 to 2016? 
55 
 
Statistical analysis: The Goodman and Kruskal’s lambda model was used to test 
the null hypothesis for Research Question 1. The independent variable set were the states 
divided into 1 group of the 4 selected states and the dependent variable set were the 
clinically significant CRE characteristics divided into 1 group of the 4 selected 
characteristics. Results from the analyses were interpreted based on the crosstabulation 
contingency table, the directional measures table, the proportional reduction error (PRE) 
value, and the p-value. 
RQ2: What is the association between the five types of confirmed health care 
acquired Carbapenemase gene mechanisms and geographical location (Colorado, Illinois, 
West Virginia, and South Dakota) reported to the CDC as of 2017? 
Statistical analysis: The Goodman and Kruskal’s lambda model was used to test 
the null hypothesis for Research Question 2. The independent variable set were the states 
divided into 1 group of the 4 selected states and the dependent variable set were the 
confirmed Carbapenemase gene mechanism divided into 1 group of the 5 gene 
mechanisms. Results from analyses were interpreted based on the crosstabulation 
contingency table, the direction measures table, the proportional reduction error (PRE) 
value, and the p-value.  
Threats to Validity 
Using a retrospective study design with secondary data I selected had inherent 
threats that exist to the internal and external validity. Since the researcher using 
secondary data do not have control over how the study population, data collection 
processes, or the quality of data that was originally collected, the lack of random 
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selection was a potential threat to the internal validity (Creswell, 2009). Conducting a 
retrospective study with nonprobability sampling was effective in creating a picture of a 
situation as in the case of this study of creating a possible prevalence picture of 
community-associated CRE cases in the United States. However, this type of sampling 
study did have an effect on the generalizability of the end results to the entire population 
by possibly having a very high confidence level. Nonprobability sampling is good for a 
hypothesis that has been generated that involves exploratory research, but the results can 
be biased along with analytical inferences. In addition to only having data that is grouped 
like the dependent data for this study into categories versus having access to the reported 
raw data also had an external threat on the representativeness along with the limited 
scope of the study, but this study is the starting point of future studies with more detailed 
CRE data that could have the potential to be properly manipulated (Frankfort-Nachmias 
& Nachmias, 2007)  
Ethical Procedures 
Institutional Review Board (IRB) approval was granted for this retrospective 
study using archival data for secondary data usage prior to performing any data analysis. 
Since the data is archival data Walden University had a shorter more abbreviated IRB 
application form that was used to get IRB approval. The archival data from all 4 selected 
state public health departments have been previously published in surveillance reports 
and the data is de-identified. The public health departments adhere to general data 
protection regulations (GDPR) and there were no ethical concerns on the patient collected 
data. The data selected from the CDC was also published data on the CDC website that 
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has also been de-identified and the CDC also adheres to GDPR on all collected data. The 
data integrity and confidentiality employed concerning this study will be maintaining the 
data collected for at least 5 years after study completion. To ensure secure data storage 
during the 5-year date duration all study data is stored in a password protected folder on a 
password protected computer. 
Summary 
In summary, the research methodology used to explore the prevalence of 
community-associated and health care acquired CRE cases with similar clinically 
significant characteristics that were in the form of a quantitative nonexperimental 
retrospective study using nonprobability sampling secondary data from the public health 
departments from 4 selected states and confirmed Carbapenemase gene mechanisms from 
the same 4 selected states and compiled by the CDC from the AR lab network. Two 
research questions were formulated to help determine the measure of the strength 
associated between clinically significant CRE reported characteristic and confirmed CRE 
gene mechanisms for 4 selected states. The secondary data sets were accessed from 
previously published surveillance reports and established CDC website reports. 
The data analyses plan included using the statistical software program SPSS in 
order to perform a Goodman and Kruskal’s lambda analyses for both research questions. 
A power of analysis was conducted for each individual research question that determined 
the appropriate sample size, alpha level, and effect size. Detailed information on the 
population demographics and the original CRE characteristics data were provided. 
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Details were also provided on the dependent and independent variables. Lastly the threat 
to internal and external validity and ethical procedures were addressed. 
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Chapter 4: Results 
Introduction 
My purpose for this quantitative nonexperimental retrospective study was to 
explore the prevalence association of CRE cases that have been reported between the 
years of 2013 thru 2016 as community-associated CRE cases and as health care acquired 
cases associated with the similar reported clinically significant CRE characteristics of 
organism identifications (E. coli, K. pneumoniae, K. oxytoca, E. aerogenes, E. cloacae, & 
Enterobacter species); specimen sources (urine, blood, wound, rectal, respiratory, & 
intra-abdominal); medical facility types (acute care, long-term acute care hospital – 
LTACH, long-term care facility – LTCF, & outpatient); and laboratory CRE gene 
mechanism detection methods (molecular testing, phenotypic testing, & antibiotic 
susceptibility testing) that had been reported to the respective state health departments in 
Colorado, Illinois, West Virginia, and South Dakota. For this study I also explored the 
association of 5 confirmed Carbapenemase gene mechanisms of Imipenemase (IMP), 
Verona Integron-encoded Metallo-beta-lactamase (VIM), Klebsiella pneumoniae 
Carbapenemase (KPC), New Delhi Metallo-beta-lactamase (NDM), and Oxacillinase-48 
(OXA-48) from the same 4 states of Colorado, Illinois, West Virginia, and South Dakota 
complied by the CDC as of 2017 from their Antimicrobial Resistant (AR) Laboratory 
Network to analyze the association of the confirmed Carbapenemase gene mechanism 
cases between the 4 states. 
The scope limitations I stated for this study were as follows: the data were only 
available in groups reported in respective state surveillance reports, since the groups were 
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not randomly selected or assigned manipulation of the independent and dependent 
variables were not possible. The CRE data reported to the respective state public health 
departments during 2013 thru 2016 were the very first of that type of data reported. The 
CRE confirmed gene mechanism data from the CDC as of 2017 was also the first of that 
type of information reported. The research questions and hypotheses of this study were as 
follows: 
Research Question 1: What is the association between CRE organism ID, 
specimen source, medical facility type, and laboratory gene mechanism detection method 
and geographical location (Colorado, Illinois, West Virginia, and South Dakota) from 
2013 to 2016? 
H01: There is no association between CRE organism ID, specimen source, 
medical facility type, and laboratory gene mechanism detection method and geographical 
location (Colorado, Illinois, West Virginia, and South Dakota) from 2013 to 2016.  
H11: There is an association between CRE organism ID, specimen source, 
medical facility type, and laboratory gene mechanism detection method and geographical 
location (Colorado, Illinois, West Virginia, and South Dakota) from 2013 to 2016.  
Research Question 2: What is the association between the 5 types of confirmed 
health care acquired Carbapenemase gene mechanisms and geographical location 
(Colorado, Illinois, West Virginia, and South Dakota) reported to the CDC as of 2017? 
H02: There is no association between the 5 types of confirmed health care 
acquired Carbapenemase gene mechanisms and geographical location (Colorado, Illinois, 
West Virginia, and South Dakota) reported to the CDC as of 2017.  
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H12: There is an association between the 5 types of confirmed health care 
acquired Carbapenemase gene mechanisms and geographical location (Colorado, Illinois, 
West Virginia, and South Dakota) reported to the CDC as of 2017. 
 Chapter 4 presents information related to the data collection processes and the 
results achieved from the analyses. I performed a compilation of the descriptive analyses 
for independent and dependent variables. The findings were presented for each research 
question and variable. There is a summary of the primary findings of the study 
conducted, and finally a transition into the interpretation of these findings in chapter 5. 
Data Collection 
The secondary data I collected for this study were obtained from 2013 thru 2017 
collectively from the respective state health departments of Colorado, Illinois, West 
Virginia, and South Dakota and confirmed gene mechanisms from the CDC as of 2017. 
The secondary archival CRE epidemiology summary data reports from the state health 
departments of Colorado, Illinois, West Virginia, and South Dakota I accessed through 
each respective state health department website and the CDC data were accessed through 
the CDC website.  
There was a small discrepancy in the data collection plan originally presented in 
chapter 3. The 5 confirmed gene mechanisms data of IMP, VIM, KPC, NDM, and OXA-
48 collected by the CDC were available according to the website for the exception of the 
KPC gene mechanism. There were no actual total number of cases reported on the CDC 
website for the KPC gene mechanism; it only listed if each state had reported KPC cases. 
I contacted the CDC in April 2019 to asked about how to get the actual number of KPC 
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cases. After several weeks and corresponding originally by phone then by email with 
several CDC representatives, I finally received an answer that the CDC historically have 
not tracked the KPC CRE counts like the other 4 carbapenemase gene mechanisms 
because the frequency of KPC CRE is so much greater. The CDC suggested that I reach 
out to the respective state’s health department personnel to get actual KPC CRE counts. I 
reached out to each state’s health department to get their respective KPC CRE counts. It 
took an additional 2 weeks to obtain the KPC counts, but I was able to get total KPC 
counts for the years that each state started collecting CRE epidemiology information. 
Sample Demographic Characteristics 
The secondary data for this study I extracted from the archival CRE epidemiology 
summary reports from 4 individual state departments of health from Colorado, Illinois, 
West Virginia, and South Dakota available on each respective state’s website. Secondary 
data I also extracted from the CDC website for the confirmed health care acquired CRE 
gene mechanism for the exception of the KPC confirmed gene mechanism, which came 
from each of the 4 states selected. 
I complied all of these data into total category sets by independent variable group 
of each of the 4 states and by each dependent variable group of gene mechanism, 
organism ID, specimen source, facility type, and lab detection method; see Table 9 below 
for sample characteristics details. By performing the Goodman and Kruskal lambda 
statistical test I was able to run the analyses using total counts (frequencies) rather than 
individual scores, so I opted for that function which required the cases to be weighted 
using SPSS processes prior to executing the actual Goodman and Kruskal lambda 
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analysis (Laerd Statistics, 2016). The case weight process I executed by performing the 
‘weight case by’ function in SPSS, which involved using each clinical characteristic 
variable group and each frequency total for that particular characteristic group (Laerd 
Statistics, 2016). There were no missing data after all of the data was compiled from the 
epidemiology reports. There were instances where there were no data collected which 
was recorded as 0 for the analysis then listed as N/R in each respective table, so no data 
were considered missing. The representative sample population cases generated from the 
4 states were in the thousands and can be seen as proportional to a larger population for 
generalizability of the results. 
Table 9 
 
CRE Case Summaries 
 CRE Case Summaries 
Valid Missing Total 
N Percent N Percent N Percent 
 
Gene Mechanism 1039 100.0% 0 0.0% 1039 100.0% 
 
Type of Organism ID 4021 100.0% 0 0.0% 4021 100.0% 
 
Type of Specimen Source 3950 100.0% 0 0.0% 3950 100.0% 
 
Medical Facility Type 4243 100.0% 0 0.0% 4243 100.0% 
 
Lab Detection Method 4482 100.0% 0 0.0% 4482 100.0% 
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Analysis Results 
For Research Question 1, four detailed analyses were completed using Goodman 
and Kruskal’s lambda statistical test for the dependent variables’ organism ID, specimen 
source, medical facility type, and lab gene detection method and for the independent 
variable, state. See the descriptive statistics for each analysis in Tables 10, 11, 12, and 13. 
An evaluation of the hypotheses follows each result analysis. 
Research Question 1: What is the association between CRE organism ID, 
specimen source, medical facility type, and laboratory gene mechanism detection method 
and geographical location (Colorado, Illinois, West Virginia, and South Dakota) from 
2013 to 2016?  
H01: There is no association between CRE organism ID, specimen source, 
medical facility type, and laboratory gene mechanism detection method and geographical 
location (Colorado, Illinois, West Virginia, and South Dakota) from 2013 to 2016.  
H11: There is an association between CRE organism ID, specimen source, 
medical facility type, and laboratory gene mechanism detection method and geographical 
location (Colorado, Illinois, West Virginia, and South Dakota) from 2013 to 2016.  
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Table 10 
 
Organism ID Descriptive Statistics 
State Organism Identification (ID) Total 
 E. 
coli 
K. 
pneumoniae 
E. 
aerogenes 
E. 
cloacae 
Enterobacter 
species 
 
Colorado 67 46 72 336 5 526 
Illinois 180 2567 N/R N/R 170 2917 
West 
Virginia 
46 153 77 159 11 446 
South 
Dakota 
9 67 9 46 1 132 
Total 302 2833 158 541 187 4021 
Note. N/R = none reported. 
I used Goodman and Kruskal’s l to determine whether the CRE organism ID 
isolated and reported by the state’s health department could be better predicted by 
knowledge of the state where the CRE organism ID originated from. The Goodman and 
Kruskal’s l was .249. This was a statistically significant reduction in the proportion of 
errors due to knowledge of the selected state as a predictor of CRE organism ID isolated, 
p<.001. The alternate hypothesis that there is a significant association for the organism 
ID between the 4 states is supported which rejects the null hypothesis that there is no 
association. The organism ID most abundantly reported was K. pneumoniae and from 
Illinois; in addition, the state of Illinois did not report any E. aerogenes or E. cloacae 
organism IDs. The remaining states all had data reports for all 5 organism IDs. 
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Table 11 
 
Specimen Source Descriptive Statistics 
State Specimen Source Type Total 
 Urine Blood Wound Rectal Respiratory Intra-
abdominal 
 
Colorado 341 39 31 34 37 37 519 
Illinois 1469 N/R 356 556 396 N/R 2777 
West 
Virginia 
375 15 53 16 51 N/R 510 
South 
Dakota 
83 1 19 19 19 3 144 
Total 2268 55 459 625 503 40 3950 
Note. N/R = none reported. 
 
I used Goodman and Kruskal’s l to determine whether the CRE specimen source 
type reported to the state’s health department could be a better predicted by knowledge of 
the state where the CRE specimen source type originated from. The Goodman and 
Kruskal’s l was .000. This is not a statistically significant reduction in the proportion of 
errors due to knowledge of the state as a predictor of the specimen source type reported. 
The alternative hypothesis that there is a significant association for specimen source 
between the 4 states is not supported. The null hypothesis cannot be rejected. The 
specimen source most abundantly reported was urine followed by rectal, respiratory, and 
wound. Blood and intra-abdominal represented the least reported specimen sources by the 
states. Illinois did not have any reported data for either blood or intra-abdominal 
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specimen sources. West Virginia did not have any reported data for the intra-abdominal 
source. 
Table 12 
 
Medical Facility Type Descriptive Statistics 
State Medical Facility Type Total 
 Acute Care LTACH LTCF Outpatient  
Colorado 339 22 56 121 538 
Illinois 1817 658 N/R 802 3277 
West Virginia 154 N/R 130 N/R 284 
South Dakota 82 N/R 29 33 144 
Total 2392 680 215 956 4243 
Note. N/R = none reported. LTACH = Long-Term Acute Care Hospital. LTCF = Long-
Term Care Facility. 
 
I used Goodman and Kruskal’s l to determine whether the type of medical 
facility reported to the state’s health department could be better predicted by knowledge 
of the selected state where the medical facility is located. The Goodman and Kruskal’s l 
was .000. This was not a statistically significant reduction in the proportion of errors due 
to knowledge of the selected state as a predictor of type of medical facility. The 
alternative hypothesis that there is a significant association for medical facility type 
between the 4 states is not supported. The null hypothesis cannot be rejected. Acute care 
was the leader for most reported data followed by outpatient then long-term acute care 
hospital finally long-term care facility with the least reported. Illinois did not have any 
reported long-term care facility data, but remained the leader in the most reported of all 
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facilities combined. South Dakota had no reported long-term acute care hospital data 
along with west Virginia. West Virginia did not have any reported outpatient data, which 
will be discussed more at length in chapter 5.  
Table 13 
 
Lab Gene Detection Method Descriptive Statistics 
State Lab Gene Detection Method Total 
 Molecular 
Testing 
Phenotypic 
Testing 
Antibiotic Susceptibility 
Testing 
 
Colorado 282 N/R 352 634 
Illinois 709 1574 882 3165 
West 
Virginia 
N/R N/R 490 490 
South 
Dakota 
55 55 83 193 
Total 1046 1629 1807 4482 
Note. N/R = none reported. 
 
I used Goodman and Kruskal’s l to determine whether the type of lab gene 
detection method reported to the state’s health department could be better predicted by 
knowledge of a particular state where the lab gene detection method was performed. The 
Goodman and Kruskal’s l was .259. This was a statistically significant reduction in the 
proportion of errors due to knowledge of a particular state as a predictor of the type of lab 
detection method, p<.001. The alternate hypothesis that there is a significant association 
for the lab detection method between the 4 states is supported which rejects the null 
hypothesis that there is no association. The leader for lab gene detection method among 
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the 4 states was antibiotic susceptibility testing followed by phenotypic testing with 
molecular testing with the least at 1046 reported using that detection method. The state of 
Colorado had no reported phenotypic testing data along with West Virginia. West 
Virginia was the only state with no reported molecular testing performed.  
For Research Question 2 a detailed analysis was completed using Goodman and 
Kruskal’s lambda statistical test for the dependent variable group of confirmed health 
care acquired Carbapenemase gene mechanisms for the independent variable group of 4 
states. See the descriptive statistics for analysis in Table 14. An evaluation of the 
hypothesis follows the result analysis. 
Research Question 2: What is the association between the 5 types of confirmed 
health care acquired Carbapenemase gene mechanisms and geographical location 
(Colorado, Illinois, West Virginia, and South Dakota) reported to the CDC as of 2017? 
H02: There is no association between the 5 types of confirmed health care 
acquired Carbapenemase gene mechanisms and geographical location (Colorado, Illinois, 
West Virginia, and South Dakota) reported to the CDC as of 2017.  
H12: There is an association between the 5 types of confirmed health care 
acquired Carbapenemase gene mechanisms and geographical location (Colorado, Illinois, 
West Virginia, and South Dakota) reported to the CDC as of 2017. 
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Table 14 
 
Gene Mechanisms Descriptive Statistics 
State Gene Mechanisms Total 
 IMP VIM KPC NDM OXA-48  
Colorado N/R 1 31 25 N/R 57 
Illinois 3 1 636 109 13 762 
West Virginia N/R N/R 153 N/R N/R 153 
South Dakota N/R N/R 67 N/R N/R 67 
Total 3 2 887 134 13 1039 
Note. N/R = none reported. 
 
I used Goodman and Kruskal’s l to determine whether the type of gene 
mechanism reported to the CDC or by the state’s health department could be better 
predicted by knowledge of a particular state where the gene mechanism was isolated. The 
Goodman and Kruskal’s l was .000. This was not a statistically significant reduction in 
the proportion of errors due to knowledge of a particular state as a predictor of type of 
gene mechanism isolated. The alternative hypothesis that there is a significant association 
for carbapenemase gene mechanism between the 4 states is not supported. The null 
hypothesis cannot be rejected. The only state that had all 5 confirmed health care 
acquired gene mechanism reported to the CDC was Illinois followed by Colorado with 3 
of the 5 confirmed gene mechanisms reported to the CDC. West Virginia and South 
Dakota only reported the one KPC confirmed health care acquired gene mechanism to the 
CDC. The total number of health care acquired confirmed gene mechanism among the 4 
states combined is far less than the total activity of the clinical characteristics listed for 
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both health care acquired and community-associated CRE reports for the analyses 
completed for Research Question 2. 
Summary 
The analyses of the secondary data I performed for this study tested the 
hypotheses of the 2 research questions. Research Question 1 (RQ1) contained the 
dependent variable of a clinical characteristics group that encompassed 4 characteristics 
(CRE organism ID, specimen source, medical facility type, and lab gene mechanism 
detection method) between the independent variable group that encompassed 4 selected 
states (Colorado, Illinois, West Virginia, and South Dakota). The results I generated from 
the analysis performed between the organism ID and the selected 4 states with a l of 
.249, p<.001 and the results between the lab detection method and the selected 4 states 
with a l of .259, p<.001 produced a significant association result of which the alternative 
hypothesis was supported for each of those particular characteristics. The results I 
generated from the analyses performed between the specimen source and the selected 4 
states with a l of .000 and the results between the medical facility type and the selected 4 
states with a l of .000 of which no significant association exists and fails to reject the null 
hypothesis.  
Research Question 2 (RQ2) contained the dependent variable group that 
encompassed 5 confirmed gene mechanisms (IMP, VIM, KPC, NDM, and OXA-48) 
between the independent variable group that encompassed 4 selected states (Colorado, 
Illinois, West Virginia, and South Dakota). The results I generated from the analysis 
performed between the confirmed gene mechanisms and the 4 selected states with a l of 
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.000 of which no significant association exists and fails to reject the null hypothesis. The 
representative sample population was abundant subsequently making generalization very 
possible. Chapter 5 includes the interpretation of the result findings, limitations of the 
study, recommendations for further research, and social change implications. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
For this study I used a quantitative nonexperimental design that used retrospective 
secondary data analysis using community-associated and health care acquired CRE cases 
reported between 2013 thru 2016 which was compiled from 4 selected state public health 
departments from Colorado, Illinois, West Virginia, and South Dakota as the independent 
variable group. The first dependent variable group comprised of reported clinically 
significant CRE characteristics of organism ID, specimen source, medical facility type, 
and laboratory gene mechanism detection method. The second dependent variable group 
comprised of 5 confirmed health care acquired Carbapenemase gene mechanisms of IMP, 
VIM, KPC, NDM, and OXA-48 from the CDC. All data details have been previously 
outlined. The actually KPC numbers were obtained from each state department of health. 
The reason I conducted this study was to explore the prevalence of the CRE infection 
cases, both community-associated and health care acquired, to determine if an association 
exists between geographic location and clinically significant CRE characteristics. 
Knowing the state where the CRE infection was reported reduced the probability 
of making an incorrect prediction on the organism ID by 24.9%, which makes it an 
association relationship between the selected states of (Colorado, Illinois, West Virginia, 
& South Dakota) and the organism ID of (E. coli, K. pneumoniae, E. aerogenes, E. 
cloacae, Enterobacter species). Knowing the reporting state also reduced the probability 
of making an incorrect prediction on the lab detection method by 25.9%, which makes it 
an association relationship between the selected states of (Colorado, Illinois, West 
74 
 
Virginia, & South Dakota) and the lab gene detection method of (Molecular testing, 
Phenotypic testing, & Antibiotic susceptibility testing). 
 Between the selected states of (Colorado, Illinois, West Virginia, & South 
Dakota) and specimen sources (Urine, Blood, Wound, Rectal, Respiratory, & Intra-
abdominal), medical facility types (Acute care, LTACH, LTCF, & Outpatient), and the 5 
health care confirmed Carbapenemase genes (IMP, VIM, KPC, NDM, & OXA-48) all 
produced lambda values of 0 making it a no association relationship between those 
independent and dependent variable groups.  
Interpretations of the Findings 
This study extends the knowledge of the very small list of existing studies 
exploring community-associated CRE factors in the United States. Results highlighted 
that knowing the organism ID and/or lab detection method from the 4 different selected 
states can reduce the probability of making an incorrect prediction for community-
associated CRE infections. Results also highlighted that there was a no association 
relationship for the specimen source, medical facility type, and the 5 confirmed 
carbapenemase gene mechanism between the 4 different selected states. Additional 
collaborative detailed data are needed on the characteristics of specimen source, medical 
facility type, and the 5 confirmed carbapenemase gene mechanism from community-
associated sources as well as continued health care acquired sources in order to further 
the knowledge. 
Since the data collected by the 4 selected states was the first time any data of this 
type had been collected on community-associated and health care acquired CRE, it would 
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be significant to this study to discuss the detailed results in more depth beyond just the 
lambda result values. Looking back at the organism ID descriptive statistics listed in 
Table 10, K. pneumoniae was the most abundant organism ID collected for CRE for both 
health care acquired and community-associated CRE with 2833 total reported by all 4 
selected states, but the total number of KPC health care acquired gene mechanism 
reported to the CDC was only 887 (Table 14). The fact remains that a total of 1946 cases 
of KPC CRE cases from the 4 selected states were not being considered by the CDC total 
count reports. The 887 CRE health care acquired cases reported to the CDC represented 
only a little more than 31% of the actual KPC cases that existed overall during the years 
of 2013 thru 2017 for the 4 states combined. This is significant in the fact that the 
complete KPC picture from 2013 to 2017 was not fully considered by the entire health 
care arena albeit health care acquired or community-associated. This could be a 
significant factor that could have contributed and can continue to contribute to the rise of 
community-associated CRE in the United States. Literature revealed that since the 
resistance classification named Klebsiella pneumoniae carbapenemase (KPC) came into 
existence it has rapidly and steadily increase, which is still a fact (Guh et al., 2014). Upon 
further exploration of the results detailed in Table 10 revealed that as of 2016 Illinois did 
not have any reported CRE organism IDs of E. aerogenes or E. cloacae which could be 
significant baseline exposure information if Illinois reports any of those two organism 
IDs in the future. 
For specimen source (Table 11), urine dominated the totals with 2268 cases 
compared to the other 5 specimen sources reported which was a significant number of 
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positive CRE cases that involved the source of urine. Results from a past global study 
revealed that there was evidence of an initial diagnosis of a positive CRE culture could 
have a mean time of 387 days to proven CRE negative (Zimmerman et al., 2013). This 
could be an important fact to consider when those 2268 CRE urine cases time frame it 
took for the patient to be treated from a positive CRE urine culture state to a negative 
CRE urine culture state, so again possible factors contributing to the rise of community-
associated CRE in the United States. due to the many urinary tract infections that are 
commonly treated in outpatient clinics.  
I examined the medical facility type descriptive statistics further listed in Table 12 
and it revealed that the most abundant medical facility type reported was acute care 
facility, but it was discovered that there were deficiencies in the definition of the medical 
facility types for the LTACH, LTCF, and outpatient when compared between states 
meaning not each state had the same exact definition for each facility type. Since this was 
the first time the selected states reported different medical facility types in the future it 
would be helpful to have a more universal definition for each medical facility type to help 
states report more precisely, which will help with a more precise and accurate 
comparison. West Virginia was selected and very significant to this study with regards to 
the outpatient medical facility type description category. West Virginia clearly noted in 
the 2016 surveillance report that while some CRE infections may be acquired in the 
community they do not track resistance mechanisms from laboratories due to CRE being 
historically associated with exposure to health care facilities which is why West Virginia 
had no reported outpatient cases (WVDHHR-2016, 2017). After I explored the data 
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details in all of the tables for West Virginia and considering they acknowledged that 
community-associated CRE exists but they do not track the resistance mechanisms from 
outpatient laboratories is very alarming because West Virginia could potentially have 
under reported major CRE results (WVDHHR-2016, 2017) . Since West Virginia had 
significant numbers of organism IDs, specimen sources with reported CRE information 
from only 2 medical facility types, reported only antibiotic susceptibility, and reported 
only KPC gene mechanisms from that state, West Virginia could expressively be 
contributing to those factors significant in the rise of community-associated CRE in the 
United States. 
I examined the lab gene detection methods, which revealed that Illinois, the 
largest state reporting, was able to report the most results using the molecular methods 
than the other listed detection methods. Antibiotic susceptibility testing is considered the 
least expensive followed by phenotypic testing and then molecular testing methods 
(Hrabák et al., 2014). Molecular testing methods are the most accurate and precise 
methods for confirmation of different gene resistance mechanisms that exist in the health 
care field (Hrabák et al., 2014). Depending on a facility’s budget and the experience of 
the health care professional would determine which detection method is used the most 
frequent (Hrabák et al., 2014).      
Exactly how CRE infections have emerged into the community-associated 
category in the United States is still evolving. A close examination of the study results 
made it clear that more detailed data are needed to be collected and analyzed on a more 
consistent basis from more states. Identification of CRE gene mechanisms is a very 
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important step to the identification of which patients are infected with what mechanism, 
in order to properly apply surveillance to keep transmission of these gene mechanism 
transfer low (Kaye & Pogue, 2015; Rolain & Cornaglia, 2014). Having a tool of lab gene 
detection method can continue to help with identification of the gene mechanism which 
this study confirmed has a significant association relationship of prediction. Hopefully, 
with this study I will provide the catalyst needed for more in-depth future studies with 
more detailed clinical characteristics involving community-associated CRE infections 
that can be connected in order to provide even more great insight to the emerged 
community-associated CRE in the United States. 
The theoretical framework of One Health embodies a collaborative approach to 
reducing health risks such as antibiotic resistance like CRE infections (Solomon, 2017). 
One Health promotes optimum health through continuous joint efforts of all health 
professionals, health facilities, scientists, organizations, and disciplines (Solomon, 2017). 
The One Health theory supports the fact that antibiotics that are used for humans and 
animals share some of the same molecules, which makes transmission of resistance easier 
and easier. If all entities join forces in tackling AMR, such as CRE, a reduction in health 
care and financial burden may improve the public health sector (Solomon, 2017).  
The 4 states I selected for this study were specifically targeted for the similar 
clinical characteristics that were reported involving community-associated and health 
care acquired CRE infections. The result findings of organism ID and lab gene detection 
method between the 4 selected states having a significant association relationship helped 
confirm that the One Health theory of collaborating in the form of reporting similar and 
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specific clinical characteristics can help strengthen the overall joint efforts on CRE 
infection surveillance. The Goodman and Kruskal’s l results for the CRE organism and 
lab gene detection method between the 4 selected states are very close in value (.249 and 
.259 respectively). At first observation these 2 lambda results could be regarded 
statistically as predictor variables that are highly correlated causing collinearity meaning 
they expressed a linear relationship (Laerd, 2016). However, collinearity tends to happen 
in regression type analyses that use continuous variables that are of an ordinal nature. The 
Goodman and Kruskal analyses I performed determined the strength of association 
between categorical variables with 3 or more levels, which makes the collinearity logic 
nonapplicable for these lambda results (Laerd Statistics, 2016). Each of my variable 
groups were independent of each other. Moreover, from a laboratory practice observation 
the CRE organism and lab gene detection method are correlated due to the fact that when 
both results are known it strengthens the predictability for CRE infections surveillance.      
Even though specimen source, medical facility type, and the 5-health care 
confirmed Carbapenemase gene did not produce an associated relationship in this study it 
could still be a catalyst for future studies with more detailed data involving specimen 
source, medical facility type, and the 5 confirmed Carbapenemase genes as well as more 
defined definitions of characteristics. After examining the data detailed in the result 
tables there is much more work to be done to fight this battle against community-
associated and health care acquired CRE in the United States. Even though the results 
from this study could not provide the specific and concise understanding of just how CRE 
infections have evolved from health care acquired sources to now community-associated 
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sources this study did provide informational possibilities of how community-associated 
sources could happen.  
Limitations of the Study 
For this retrospective study I used secondary data as a nonprobability sampling of 
convenience, but nonrandomized or not being assigned in selected groups of data was one 
of the inherent limitations of this study. Inherent validity threats both internal and 
external existed using a retrospective type of study design. This type of study was 
effective in the creation of a prevalence picture of community-associated CRE cases in 
the United States. since this scenario is still fairly new. 
Another limitation of this study was that each state’s data were reported in 
categorical groups instead of individual specifics, so the results were presented in 5 
different clinical characteristic groups for the 4 selected states. It was not possible to 
manipulate the data as to compare or do an analysis for example between which facility 
(e.g. acute or outpatient) reported which gene mechanism type (e.g. KPC or VIM). It was 
also not possible to calculate any trends for any of the data as a comparison. Moreover, 
the previous mentioned limitation also created a strength for this study which was the 
large sample data numbers generated after compiling all of the data from the surveillance 
reports from each of the 4 selected states. So, the high yield number of data collected for 
the study that involved the clinical characteristics of organism ID, lab detection methods, 
medical facility types, specimen sources, and gene mechanisms between the selected 
states generated end results for the generalizability to an entire population was not a 
problem.  
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Recommendations 
Referencing back to the theoretical foundation framework of One Health I 
selected for this study, the concept promotes people, animals, and the environment that 
can achieve optimum health (Solomon, 2017). Continuous joint efforts based on the fact 
that antibiotics used for human and animals share the same molecules which makes 
transmission for antibiotic resistance easier than realized between humans and animals 
either directly or by way of the environment (Solomon, 2017). One Health supports 
expanding surveillance from just solely focused on human antibiotic and consumption 
data from hospitals and community to also incorporating surveillance data to included 
animals, food, and the environment (Queenan et al., 2016). Although addressing animal, 
food, and the environment for community-associated CRE for data analysis was out of 
scope for this study, existing literature were reviewed on those sources when exploring 
CRE gene transmission. The literature I reviewed was quite compelling and introduced 
several factors that exist in other countries but have not yet been explored in the United 
States before that suggests other facets of community-associated CRE gene acquired and 
transmission cases (Abraham et al., 2014; Guerra et al., 2014). One of those compelling 
studies was conducted in Australia by researchers that involved the relationship between 
humans and their companion pets by way of cross bacteria species transmission 
(Abraham et al., 2014). Another compelling study was conducted in Germany by 
researchers that involved food producing sources such as livestock, wildlife, and seafood 
and the gram negative organism relationship between soil and irrigation water (Guerra et 
al., 2014). These studies are just a few examples that could only bring about awareness to 
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the possibility of other alternative sources of CRE exposures from the community for 
future studies in the United States. 
The end study results and literature review information generated from this study 
are also definite catalysts for further research for the exploration of other factors 
contributing to community-associated CRE infection in the United States. In order to 
fully comprehend the migration of CRE from health care type facilities only is to also 
include community type setting as well. The biggest recommendation would be for the 
CDC to get more involved in the surveillance of CRE cases other than just health care 
acquired due to the exponential rise in community-associated CRE. The individual U.S. 
states are putting forth an effort but will need guidance in what details to report for across 
the board consistent clear definitions on clinical characteristics such as facility types and 
categories (e.g. laboratory, outpatient) for future concise result reporting.   
Social Change Implications 
With this study I confirmed that having the knowledge of some specific clinical 
characteristics related to community-associated CRE infections can improve the 
knowledge of what factors can be used to predict their existence, which is a start that can 
help improve public CRE health. Even though this study was small in nature it added 
some new information to the small number of existing studies of CRE contributing 
factors in the United States. and this is a serious potential social change implication. Any 
positive information can start to build upon the contribution greatly needed at reducing 
the spread of CRE infections which can also help in the reduction of the economic burden 
of CRE infections associated with the per capita cost of health care no matter how 
83 
 
miniscule the knowledge. The number 1 goal is to continue to provide information that 
will contribute to actions that will preserve the carbapenem class of antibiotics for when 
they are truly needed while at the same time preserving the quality of life which will also 
help save lives. Hopefully this study along with the other few studies that exist on 
contributing factors to community-associated CRE will capture the attention of health 
professionals, health care facilities prescribers, researchers, state health departments and 
policymakers to improve practices, policy, and the collection of surveillance data 
pertaining to antibiotic resistance overall with special attention to CRE infections. This 
collaboration would be a perfect example of the One Health theoretical processes at work 
for tackling antibiotic resistance for the future.   
Conclusion 
With the results of this study I established for the first time a significant 
association relationship for the clinical characteristics of organism ID and lab gene 
detection method between the selected states of Colorado, Illinois, West Virginia, and 
South Dakota. By knowing the selected states, a reduction in the probability of making an 
incorrect prediction on the organism ID and lab gene detection method is a major 
breakthrough for added knowledge to factors contributing to community-associated CRE 
infections in the United States.  
My purpose for this study was to explore the prevalence of CRE infection cases 
that have been reported between 2013 thru 2016 as community-associated CRE cases and 
as health care acquired cases. The similar reported clinically significant CRE 
characteristics of organism identification, specimen source, medical facility type, 
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laboratory CRE gene mechanism detection method, and the 5 confirmed carbapenemase 
mechanism IMP, VIM, KPC, NDM, and OXA-48 were compared between the 4 selected 
states of Colorado, Illinois, West Virginia, and South Dakota. In this study I was 
productive and successful in providing valuable information regarding CRE prevalence. 
Although my study’s positive associated results achieved were small it provided a 
big step towards a connection in the predictions of organism ID and lab gene detection 
methods. Moreover, this study’s negative associated results provide some useful 
information for possible future studies. Unless all health care entities join forces together 
CRE infections regardless of the origin health care acquired and community-associated 
will not improve unless some action has been taken. The public’s health deserves a future 
free of CRE prevalence cases regardless if it is health care acquired or community-
associated. The public’s health deserves to have antimicrobials that will work for difficult 
to treat infections when needed. The alternative will be CRE cases that will continue to 
grow along with the health care costs, the financial burden, and no available 
antimicrobials to treat difficult infections. Just say no to the alternative scenario.  
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